| ENSG00000186842.4 |
Dasatinib |
Breast invasive carcinoma |
0.033063056 |
Resistant |
| ENSG00000223382.3 |
Dasatinib |
Breast invasive carcinoma |
0.01924777 |
Resistant |
| ENSG00000227107.1 |
Dasatinib |
Breast invasive carcinoma |
0.007089209 |
Resistant |
| ENSG00000227857.2 |
Dasatinib |
Breast invasive carcinoma |
0.045781457 |
Resistant |
| ENSG00000230555.2 |
Dasatinib |
Breast invasive carcinoma |
0.046282636 |
Resistant |
| ENSG00000234006.1 |
Dasatinib |
Breast invasive carcinoma |
0.031304754 |
Resistant |
| ENSG00000236908.2 |
Dasatinib |
Breast invasive carcinoma |
0.02117453 |
Resistant |
| ENSG00000237457.2 |
Dasatinib |
Breast invasive carcinoma |
0.014656995 |
Resistant |
| ENSG00000237940.3 |
Dasatinib |
Breast invasive carcinoma |
0.031162916 |
Resistant |
| ENSG00000240137.1 |
Dasatinib |
Breast invasive carcinoma |
0.033809441 |
Resistant |
| ENSG00000241505.1 |
Dasatinib |
Breast invasive carcinoma |
0.042448176 |
Resistant |
| ENSG00000245105.1 |
Dasatinib |
Breast invasive carcinoma |
0.049380974 |
Resistant |
| ENSG00000248771.1 |
Dasatinib |
Breast invasive carcinoma |
0.041187615 |
Resistant |
| ENSG00000248932.1 |
Dasatinib |
Breast invasive carcinoma |
0.044390936 |
Resistant |
| ENSG00000249042.1 |
Dasatinib |
Breast invasive carcinoma |
0.045330843 |
Resistant |
| ENSG00000250366.2 |
Dasatinib |
Breast invasive carcinoma |
0.030285734 |
Resistant |
| ENSG00000250765.1 |
Dasatinib |
Breast invasive carcinoma |
0.046086866 |
Resistant |
| ENSG00000253878.1 |
Dasatinib |
Breast invasive carcinoma |
0.02724253 |
Resistant |
| ENSG00000253982.1 |
Dasatinib |
Breast invasive carcinoma |
0.02694745 |
Resistant |
| ENSG00000260032.1 |
Dasatinib |
Breast invasive carcinoma |
0.014801856 |
Resistant |
| ENSG00000260790.1 |
Dasatinib |
Breast invasive carcinoma |
0.039964691 |
Resistant |
| ENSG00000260919.1 |
Dasatinib |
Breast invasive carcinoma |
0.024137514 |
Resistant |
| ENSG00000260923.1 |
Dasatinib |
Breast invasive carcinoma |
0.045729733 |
Resistant |
| ENSG00000261469.1 |
Dasatinib |
Breast invasive carcinoma |
0.043920499 |
Resistant |
| ENSG00000261600.1 |
Dasatinib |
Breast invasive carcinoma |
0.045257928 |
Resistant |
| ENSG00000267498.1 |
Dasatinib |
Breast invasive carcinoma |
0.047311142 |
Resistant |
| ENSG00000269923.1 |
Dasatinib |
Breast invasive carcinoma |
0.016811887 |
Resistant |
| ENSG00000269961.1 |
Dasatinib |
Breast invasive carcinoma |
0.031739476 |
Resistant |
| ENSG00000272172.1 |
Dasatinib |
Breast invasive carcinoma |
0.025919927 |
Resistant |
| ENSG00000214049.6 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010370301 |
Resistant |
| ENSG00000223907.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00157111 |
Resistant |
| ENSG00000224930.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041010023 |
Resistant |
| ENSG00000226335.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007090288 |
Resistant |
| ENSG00000228682.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005133668 |
Resistant |
| ENSG00000230046.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048056259 |
Resistant |
| ENSG00000234880.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0000229 |
Resistant |
| ENSG00000242512.4 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0096649 |
Resistant |
| ENSG00000244300.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008150114 |
Resistant |
| ENSG00000249423.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018091137 |
Resistant |
| ENSG00000260132.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003902864 |
Resistant |
| ENSG00000260581.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039456874 |
Resistant |
| ENSG00000261925.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000429995 |
Resistant |
| ENSG00000175701.6 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.017658083 |
Resistant |
| ENSG00000214559.3 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.032954539 |
Resistant |
| ENSG00000225760.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.022410906 |
Resistant |
| ENSG00000226089.2 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.012468277 |
Resistant |
| ENSG00000227740.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.049935587 |
Resistant |
| ENSG00000228115.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.007596075 |
Resistant |
| ENSG00000230337.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.045852149 |
Resistant |
| ENSG00000230606.6 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.049354388 |
Resistant |
| ENSG00000231607.4 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.011625459 |
Resistant |
| ENSG00000232487.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.047507178 |
Resistant |
| ENSG00000233554.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.048905359 |
Resistant |
| ENSG00000234191.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.031069039 |
Resistant |
| ENSG00000237301.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.026142486 |
Resistant |
| ENSG00000240288.3 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.021031417 |
Resistant |
| ENSG00000241481.2 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.023349857 |
Resistant |
| ENSG00000245552.2 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.008040698 |
Resistant |
| ENSG00000251175.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.042939432 |
Resistant |
| ENSG00000260830.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.048812219 |
Resistant |
| ENSG00000260936.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.046220475 |
Resistant |
| ENSG00000261000.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.036581821 |
Resistant |
| ENSG00000270062.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.035950448 |
Resistant |
| ENSG00000272103.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.046139808 |
Resistant |
| ENSG00000272744.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.024168469 |
Resistant |
| ENSG00000272861.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.021214431 |
Resistant |
| ENSG00000088970.11 |
Dasatinib |
Brain lower grade glioma |
0.011543304 |
Resistant |
| ENSG00000104691.10 |
Dasatinib |
Brain lower grade glioma |
0.013865151 |
Resistant |
| ENSG00000124835.2 |
Dasatinib |
Brain lower grade glioma |
0.042134682 |
Resistant |
| ENSG00000131484.3 |
Dasatinib |
Brain lower grade glioma |
0.022869792 |
Resistant |
| ENSG00000152487.6 |
Dasatinib |
Brain lower grade glioma |
0.023225305 |
Resistant |
| ENSG00000163597.10 |
Dasatinib |
Brain lower grade glioma |
0.016896062 |
Resistant |
| ENSG00000170161.6 |
Dasatinib |
Brain lower grade glioma |
0.035194019 |
Resistant |
| ENSG00000172250.10 |
Dasatinib |
Brain lower grade glioma |
0.049006496 |
Resistant |
| ENSG00000173867.8 |
Dasatinib |
Brain lower grade glioma |
0.003333662 |
Resistant |
| ENSG00000175147.7 |
Dasatinib |
Brain lower grade glioma |
0.041989736 |
Resistant |
| ENSG00000177640.11 |
Dasatinib |
Brain lower grade glioma |
0.034509034 |
Resistant |
| ENSG00000178440.5 |
Dasatinib |
Brain lower grade glioma |
0.019582444 |
Resistant |
| ENSG00000179818.9 |
Dasatinib |
Brain lower grade glioma |
0.00304893 |
Resistant |
| ENSG00000180458.2 |
Dasatinib |
Brain lower grade glioma |
0.029425576 |
Resistant |
| ENSG00000181798.2 |
Dasatinib |
Brain lower grade glioma |
0.024783454 |
Resistant |
| ENSG00000184068.2 |
Dasatinib |
Brain lower grade glioma |
0.043550591 |
Resistant |
| ENSG00000185044.10 |
Dasatinib |
Brain lower grade glioma |
0.034206606 |
Resistant |
| ENSG00000185203.7 |
Dasatinib |
Brain lower grade glioma |
0.008786509 |
Resistant |
| ENSG00000196553.9 |
Dasatinib |
Brain lower grade glioma |
0.048772761 |
Resistant |
| ENSG00000196559.3 |
Dasatinib |
Brain lower grade glioma |
0.018552967 |
Resistant |
| ENSG00000196951.6 |
Dasatinib |
Brain lower grade glioma |
0.024714023 |
Resistant |
| ENSG00000197291.4 |
Dasatinib |
Brain lower grade glioma |
0.020205919 |
Resistant |
| ENSG00000197308.4 |
Dasatinib |
Brain lower grade glioma |
0.022155098 |
Resistant |
| ENSG00000197332.7 |
Dasatinib |
Brain lower grade glioma |
0.003441172 |
Resistant |
| ENSG00000198221.7 |
Dasatinib |
Brain lower grade glioma |
0.007140882 |
Resistant |
| ENSG00000203288.3 |
Dasatinib |
Brain lower grade glioma |
0.039872379 |
Resistant |
| ENSG00000203362.2 |
Dasatinib |
Brain lower grade glioma |
0.00044583 |
Resistant |
| ENSG00000203441.2 |
Dasatinib |
Brain lower grade glioma |
0.007796305 |
Resistant |
| ENSG00000203739.3 |
Dasatinib |
Brain lower grade glioma |
0.022996701 |
Resistant |
| ENSG00000204623.4 |
Dasatinib |
Brain lower grade glioma |
0.002326918 |
Resistant |
| ENSG00000204791.4 |
Dasatinib |
Brain lower grade glioma |
0.011120859 |
Resistant |
| ENSG00000204802.3 |
Dasatinib |
Brain lower grade glioma |
0.027189302 |
Resistant |
| ENSG00000204837.2 |
Dasatinib |
Brain lower grade glioma |
0.025495602 |
Resistant |
| ENSG00000205662.2 |
Dasatinib |
Brain lower grade glioma |
0.04742646 |
Resistant |
| ENSG00000205663.5 |
Dasatinib |
Brain lower grade glioma |
0.047828631 |
Resistant |
| ENSG00000205959.3 |
Dasatinib |
Brain lower grade glioma |
0.030981251 |
Resistant |
| ENSG00000206028.1 |
Dasatinib |
Brain lower grade glioma |
0.035267204 |
Resistant |
| ENSG00000206195.6 |
Dasatinib |
Brain lower grade glioma |
0.002199128 |
Resistant |
| ENSG00000212694.4 |
Dasatinib |
Brain lower grade glioma |
0.04609936 |
Resistant |
| ENSG00000214725.3 |
Dasatinib |
Brain lower grade glioma |
0.004643005 |
Resistant |
| ENSG00000214770.2 |
Dasatinib |
Brain lower grade glioma |
0.001300839 |
Resistant |
| ENSG00000214837.4 |
Dasatinib |
Brain lower grade glioma |
0.014456555 |
Resistant |
| ENSG00000215394.4 |
Dasatinib |
Brain lower grade glioma |
0.021726403 |
Resistant |
| ENSG00000215424.5 |
Dasatinib |
Brain lower grade glioma |
0.004524768 |
Resistant |
| ENSG00000215866.3 |
Dasatinib |
Brain lower grade glioma |
0.002071166 |
Resistant |
| ENSG00000217576.7 |
Dasatinib |
Brain lower grade glioma |
0.003087032 |
Resistant |
| ENSG00000223374.1 |
Dasatinib |
Brain lower grade glioma |
0.032395258 |
Resistant |
| ENSG00000223660.1 |
Dasatinib |
Brain lower grade glioma |
0.009074118 |
Resistant |
| ENSG00000223745.3 |
Dasatinib |
Brain lower grade glioma |
0.049092284 |
Resistant |
| ENSG00000223842.1 |
Dasatinib |
Brain lower grade glioma |
0.036717649 |
Resistant |
| ENSG00000223884.1 |
Dasatinib |
Brain lower grade glioma |
0.002681307 |
Resistant |
| ENSG00000223960.2 |
Dasatinib |
Brain lower grade glioma |
0.010262483 |
Resistant |
| ENSG00000224031.1 |
Dasatinib |
Brain lower grade glioma |
0.040021397 |
Resistant |
| ENSG00000224032.2 |
Dasatinib |
Brain lower grade glioma |
0.003457308 |
Resistant |
| ENSG00000224043.3 |
Dasatinib |
Brain lower grade glioma |
0.00070833 |
Resistant |
| ENSG00000224078.8 |
Dasatinib |
Brain lower grade glioma |
0.035841813 |
Resistant |
| ENSG00000224167.1 |
Dasatinib |
Brain lower grade glioma |
0.002642526 |
Resistant |
| ENSG00000224276.1 |
Dasatinib |
Brain lower grade glioma |
0.002215341 |
Resistant |
| ENSG00000224358.1 |
Dasatinib |
Brain lower grade glioma |
0.003223854 |
Resistant |
| ENSG00000224490.1 |
Dasatinib |
Brain lower grade glioma |
0.046310613 |
Resistant |
| ENSG00000224505.2 |
Dasatinib |
Brain lower grade glioma |
0.003209874 |
Resistant |
| ENSG00000224616.1 |
Dasatinib |
Brain lower grade glioma |
0.01940066 |
Resistant |
| ENSG00000224635.1 |
Dasatinib |
Brain lower grade glioma |
0.019694696 |
Resistant |
| ENSG00000224699.4 |
Dasatinib |
Brain lower grade glioma |
0.013939802 |
Resistant |
| ENSG00000224713.3 |
Dasatinib |
Brain lower grade glioma |
0.049696353 |
Resistant |
| ENSG00000224729.4 |
Dasatinib |
Brain lower grade glioma |
0.023537385 |
Resistant |
| ENSG00000224790.1 |
Dasatinib |
Brain lower grade glioma |
0.017645302 |
Resistant |
| ENSG00000224799.1 |
Dasatinib |
Brain lower grade glioma |
0.019571611 |
Resistant |
| ENSG00000224844.1 |
Dasatinib |
Brain lower grade glioma |
0.030737171 |
Resistant |
| ENSG00000224914.2 |
Dasatinib |
Brain lower grade glioma |
0.028015483 |
Resistant |
| ENSG00000224934.2 |
Dasatinib |
Brain lower grade glioma |
0.005155115 |
Resistant |
| ENSG00000225210.5 |
Dasatinib |
Brain lower grade glioma |
0.013008321 |
Resistant |
| ENSG00000225218.1 |
Dasatinib |
Brain lower grade glioma |
0.02671687 |
Resistant |
| ENSG00000225255.2 |
Dasatinib |
Brain lower grade glioma |
0.039754889 |
Resistant |
| ENSG00000225278.3 |
Dasatinib |
Brain lower grade glioma |
0.023801257 |
Resistant |
| ENSG00000225376.1 |
Dasatinib |
Brain lower grade glioma |
0.040195567 |
Resistant |
| ENSG00000225439.2 |
Dasatinib |
Brain lower grade glioma |
0.006353646 |
Resistant |
| ENSG00000225465.6 |
Dasatinib |
Brain lower grade glioma |
0.033780224 |
Resistant |
| ENSG00000225527.1 |
Dasatinib |
Brain lower grade glioma |
0.001952413 |
Resistant |
| ENSG00000225767.1 |
Dasatinib |
Brain lower grade glioma |
0.026843577 |
Resistant |
| ENSG00000225783.2 |
Dasatinib |
Brain lower grade glioma |
0.033010274 |
Resistant |
| ENSG00000225889.3 |
Dasatinib |
Brain lower grade glioma |
0.038626585 |
Resistant |
| ENSG00000225891.1 |
Dasatinib |
Brain lower grade glioma |
0.024564938 |
Resistant |
| ENSG00000225930.3 |
Dasatinib |
Brain lower grade glioma |
0.029721307 |
Resistant |
| ENSG00000226007.2 |
Dasatinib |
Brain lower grade glioma |
0.044350899 |
Resistant |
| ENSG00000226009.1 |
Dasatinib |
Brain lower grade glioma |
0.007688228 |
Resistant |
| ENSG00000226029.1 |
Dasatinib |
Brain lower grade glioma |
0.010229667 |
Resistant |
| ENSG00000226200.2 |
Dasatinib |
Brain lower grade glioma |
0.035773396 |
Resistant |
| ENSG00000226245.1 |
Dasatinib |
Brain lower grade glioma |
0.001190953 |
Resistant |
| ENSG00000226352.2 |
Dasatinib |
Brain lower grade glioma |
0.026016133 |
Resistant |
| ENSG00000226381.3 |
Dasatinib |
Brain lower grade glioma |
0.040652948 |
Resistant |
| ENSG00000226471.2 |
Dasatinib |
Brain lower grade glioma |
0.016078374 |
Resistant |
| ENSG00000226688.2 |
Dasatinib |
Brain lower grade glioma |
0.022848166 |
Resistant |
| ENSG00000226696.1 |
Dasatinib |
Brain lower grade glioma |
0.009254487 |
Resistant |
| ENSG00000226746.2 |
Dasatinib |
Brain lower grade glioma |
0.017607473 |
Resistant |
| ENSG00000226772.1 |
Dasatinib |
Brain lower grade glioma |
0.042096006 |
Resistant |
| ENSG00000226833.1 |
Dasatinib |
Brain lower grade glioma |
0.041472847 |
Resistant |
| ENSG00000226852.2 |
Dasatinib |
Brain lower grade glioma |
0.032072387 |
Resistant |
| ENSG00000226877.3 |
Dasatinib |
Brain lower grade glioma |
0.000166791 |
Resistant |
| ENSG00000226889.3 |
Dasatinib |
Brain lower grade glioma |
0.047552102 |
Resistant |
| ENSG00000226920.1 |
Dasatinib |
Brain lower grade glioma |
0.001308551 |
Resistant |
| ENSG00000227107.1 |
Dasatinib |
Brain lower grade glioma |
0.015514253 |
Resistant |
| ENSG00000227136.2 |
Dasatinib |
Brain lower grade glioma |
0.041027414 |
Resistant |
| ENSG00000227245.1 |
Dasatinib |
Brain lower grade glioma |
0.004707331 |
Resistant |
| ENSG00000227248.1 |
Dasatinib |
Brain lower grade glioma |
0.005984451 |
Resistant |
| ENSG00000227354.2 |
Dasatinib |
Brain lower grade glioma |
0.006440899 |
Resistant |
| ENSG00000227388.2 |
Dasatinib |
Brain lower grade glioma |
0.024192951 |
Resistant |
| ENSG00000227409.1 |
Dasatinib |
Brain lower grade glioma |
0.020270387 |
Resistant |
| ENSG00000227518.2 |
Dasatinib |
Brain lower grade glioma |
0.001783 |
Resistant |
| ENSG00000227540.1 |
Dasatinib |
Brain lower grade glioma |
0.000321632 |
Resistant |
| ENSG00000227542.1 |
Dasatinib |
Brain lower grade glioma |
0.028369296 |
Resistant |
| ENSG00000227543.3 |
Dasatinib |
Brain lower grade glioma |
0.041412559 |
Resistant |
| ENSG00000227627.1 |
Dasatinib |
Brain lower grade glioma |
0.000273596 |
Resistant |
| ENSG00000227673.1 |
Dasatinib |
Brain lower grade glioma |
0.041614553 |
Resistant |
| ENSG00000227698.1 |
Dasatinib |
Brain lower grade glioma |
0.012422395 |
Resistant |
| ENSG00000227704.1 |
Dasatinib |
Brain lower grade glioma |
0.003724037 |
Resistant |
| ENSG00000227719.1 |
Dasatinib |
Brain lower grade glioma |
0.04334706 |
Resistant |
| ENSG00000227811.2 |
Dasatinib |
Brain lower grade glioma |
0.009659474 |
Resistant |
| ENSG00000227896.2 |
Dasatinib |
Brain lower grade glioma |
0.021455559 |
Resistant |
| ENSG00000228084.1 |
Dasatinib |
Brain lower grade glioma |
0.0382448 |
Resistant |
| ENSG00000228126.1 |
Dasatinib |
Brain lower grade glioma |
0.023327998 |
Resistant |
| ENSG00000228135.1 |
Dasatinib |
Brain lower grade glioma |
0.012208807 |
Resistant |
| ENSG00000228137.1 |
Dasatinib |
Brain lower grade glioma |
0.00392359 |
Resistant |
| ENSG00000228201.1 |
Dasatinib |
Brain lower grade glioma |
0.038072799 |
Resistant |
| ENSG00000228214.2 |
Dasatinib |
Brain lower grade glioma |
0.031411435 |
Resistant |
| ENSG00000228251.1 |
Dasatinib |
Brain lower grade glioma |
0.033681196 |
Resistant |
| ENSG00000228274.3 |
Dasatinib |
Brain lower grade glioma |
0.013207453 |
Resistant |
| ENSG00000228294.2 |
Dasatinib |
Brain lower grade glioma |
0.027257771 |
Resistant |
| ENSG00000228302.2 |
Dasatinib |
Brain lower grade glioma |
0.004153838 |
Resistant |
| ENSG00000228315.7 |
Dasatinib |
Brain lower grade glioma |
0.034856993 |
Resistant |
| ENSG00000228506.1 |
Dasatinib |
Brain lower grade glioma |
0.027645265 |
Resistant |
| ENSG00000228544.1 |
Dasatinib |
Brain lower grade glioma |
0.003975249 |
Resistant |
| ENSG00000228604.3 |
Dasatinib |
Brain lower grade glioma |
0.026127462 |
Resistant |
| ENSG00000228629.2 |
Dasatinib |
Brain lower grade glioma |
0.031954705 |
Resistant |
| ENSG00000228839.1 |
Dasatinib |
Brain lower grade glioma |
0.049056408 |
Resistant |
| ENSG00000228886.1 |
Dasatinib |
Brain lower grade glioma |
0.027884035 |
Resistant |
| ENSG00000228939.1 |
Dasatinib |
Brain lower grade glioma |
0.013005048 |
Resistant |
| ENSG00000228952.1 |
Dasatinib |
Brain lower grade glioma |
0.031071252 |
Resistant |
| ENSG00000229127.1 |
Dasatinib |
Brain lower grade glioma |
0.010595368 |
Resistant |
| ENSG00000229558.1 |
Dasatinib |
Brain lower grade glioma |
0.037162944 |
Resistant |
| ENSG00000229587.2 |
Dasatinib |
Brain lower grade glioma |
0.001492 |
Resistant |
| ENSG00000229589.1 |
Dasatinib |
Brain lower grade glioma |
0.015847538 |
Resistant |
| ENSG00000229728.1 |
Dasatinib |
Brain lower grade glioma |
0.008053563 |
Resistant |
| ENSG00000229869.1 |
Dasatinib |
Brain lower grade glioma |
0.033326433 |
Resistant |
| ENSG00000229955.1 |
Dasatinib |
Brain lower grade glioma |
0.030119418 |
Resistant |
| ENSG00000229956.5 |
Dasatinib |
Brain lower grade glioma |
0.013994423 |
Resistant |
| ENSG00000229999.2 |
Dasatinib |
Brain lower grade glioma |
0.023793294 |
Resistant |
| ENSG00000230021.3 |
Dasatinib |
Brain lower grade glioma |
0.040281175 |
Resistant |
| ENSG00000230124.2 |
Dasatinib |
Brain lower grade glioma |
0.014682227 |
Resistant |
| ENSG00000230177.1 |
Dasatinib |
Brain lower grade glioma |
0.002710398 |
Resistant |
| ENSG00000230303.1 |
Dasatinib |
Brain lower grade glioma |
0.036795536 |
Resistant |
| ENSG00000230366.5 |
Dasatinib |
Brain lower grade glioma |
0.003125886 |
Resistant |
| ENSG00000230506.1 |
Dasatinib |
Brain lower grade glioma |
0.017488737 |
Resistant |
| ENSG00000230530.1 |
Dasatinib |
Brain lower grade glioma |
0.039468866 |
Resistant |
| ENSG00000230552.1 |
Dasatinib |
Brain lower grade glioma |
0.022394331 |
Resistant |
| ENSG00000230565.1 |
Dasatinib |
Brain lower grade glioma |
0.000566999 |
Resistant |
| ENSG00000230612.1 |
Dasatinib |
Brain lower grade glioma |
0.010254742 |
Resistant |
| ENSG00000230648.1 |
Dasatinib |
Brain lower grade glioma |
0.002448166 |
Resistant |
| ENSG00000230699.2 |
Dasatinib |
Brain lower grade glioma |
0.032153032 |
Resistant |
| ENSG00000230736.2 |
Dasatinib |
Brain lower grade glioma |
0.011087062 |
Resistant |
| ENSG00000230747.1 |
Dasatinib |
Brain lower grade glioma |
0.036017025 |
Resistant |
| ENSG00000230850.3 |
Dasatinib |
Brain lower grade glioma |
0.01011185 |
Resistant |
| ENSG00000230912.1 |
Dasatinib |
Brain lower grade glioma |
0.000617803 |
Resistant |
| ENSG00000231074.4 |
Dasatinib |
Brain lower grade glioma |
0.016384151 |
Resistant |
| ENSG00000231079.3 |
Dasatinib |
Brain lower grade glioma |
0.047073561 |
Resistant |
| ENSG00000231154.1 |
Dasatinib |
Brain lower grade glioma |
0.010837813 |
Resistant |
| ENSG00000231160.5 |
Dasatinib |
Brain lower grade glioma |
0.025964464 |
Resistant |
| ENSG00000231294.1 |
Dasatinib |
Brain lower grade glioma |
0.029254309 |
Resistant |
| ENSG00000231305.3 |
Dasatinib |
Brain lower grade glioma |
0.031837383 |
Resistant |
| ENSG00000231393.1 |
Dasatinib |
Brain lower grade glioma |
0.026138561 |
Resistant |
| ENSG00000231439.3 |
Dasatinib |
Brain lower grade glioma |
0.014166169 |
Resistant |
| ENSG00000231473.2 |
Dasatinib |
Brain lower grade glioma |
0.006297377 |
Resistant |
| ENSG00000231512.1 |
Dasatinib |
Brain lower grade glioma |
0.047247756 |
Resistant |
| ENSG00000231612.1 |
Dasatinib |
Brain lower grade glioma |
0.036464001 |
Resistant |
| ENSG00000231616.4 |
Dasatinib |
Brain lower grade glioma |
0.000798468 |
Resistant |
| ENSG00000231731.3 |
Dasatinib |
Brain lower grade glioma |
0.015163118 |
Resistant |
| ENSG00000231889.3 |
Dasatinib |
Brain lower grade glioma |
0.002889488 |
Resistant |
| ENSG00000231976.3 |
Dasatinib |
Brain lower grade glioma |
0.040126066 |
Resistant |
| ENSG00000232046.2 |
Dasatinib |
Brain lower grade glioma |
0.041843553 |
Resistant |
| ENSG00000232063.1 |
Dasatinib |
Brain lower grade glioma |
0.032660342 |
Resistant |
| ENSG00000232116.2 |
Dasatinib |
Brain lower grade glioma |
0.044123605 |
Resistant |
| ENSG00000232300.1 |
Dasatinib |
Brain lower grade glioma |
0.035563095 |
Resistant |
| ENSG00000232336.1 |
Dasatinib |
Brain lower grade glioma |
0.022073209 |
Resistant |
| ENSG00000232470.1 |
Dasatinib |
Brain lower grade glioma |
0.027889506 |
Resistant |
| ENSG00000232593.2 |
Dasatinib |
Brain lower grade glioma |
0.035414917 |
Resistant |
| ENSG00000232613.2 |
Dasatinib |
Brain lower grade glioma |
0.010029248 |
Resistant |
| ENSG00000232638.1 |
Dasatinib |
Brain lower grade glioma |
0.023489543 |
Resistant |
| ENSG00000232640.1 |
Dasatinib |
Brain lower grade glioma |
0.004235181 |
Resistant |
| ENSG00000232677.2 |
Dasatinib |
Brain lower grade glioma |
0.001277497 |
Resistant |
| ENSG00000232710.1 |
Dasatinib |
Brain lower grade glioma |
0.043329871 |
Resistant |
| ENSG00000232828.1 |
Dasatinib |
Brain lower grade glioma |
0.020734219 |
Resistant |
| ENSG00000232909.1 |
Dasatinib |
Brain lower grade glioma |
0.012375085 |
Resistant |
| ENSG00000232936.1 |
Dasatinib |
Brain lower grade glioma |
0.045435826 |
Resistant |
| ENSG00000232956.4 |
Dasatinib |
Brain lower grade glioma |
0.011812111 |
Resistant |
| ENSG00000233044.1 |
Dasatinib |
Brain lower grade glioma |
0.047801065 |
Resistant |
| ENSG00000233056.1 |
Dasatinib |
Brain lower grade glioma |
0.040535076 |
Resistant |
| ENSG00000233154.1 |
Dasatinib |
Brain lower grade glioma |
0.048573415 |
Resistant |
| ENSG00000233178.3 |
Dasatinib |
Brain lower grade glioma |
0.036638234 |
Resistant |
| ENSG00000233223.2 |
Dasatinib |
Brain lower grade glioma |
0.01759016 |
Resistant |
| ENSG00000233396.3 |
Dasatinib |
Brain lower grade glioma |
0.040576077 |
Resistant |
| ENSG00000233427.1 |
Dasatinib |
Brain lower grade glioma |
0.03304595 |
Resistant |
| ENSG00000233515.1 |
Dasatinib |
Brain lower grade glioma |
0.021630897 |
Resistant |
| ENSG00000233613.1 |
Dasatinib |
Brain lower grade glioma |
0.000668724 |
Resistant |
| ENSG00000233718.1 |
Dasatinib |
Brain lower grade glioma |
0.027753152 |
Resistant |
| ENSG00000233757.2 |
Dasatinib |
Brain lower grade glioma |
0.001213592 |
Resistant |
| ENSG00000233791.1 |
Dasatinib |
Brain lower grade glioma |
0.035851801 |
Resistant |
| ENSG00000233806.3 |
Dasatinib |
Brain lower grade glioma |
0.029704523 |
Resistant |
| ENSG00000233937.2 |
Dasatinib |
Brain lower grade glioma |
0.003413532 |
Resistant |
| ENSG00000234028.3 |
Dasatinib |
Brain lower grade glioma |
0.014988157 |
Resistant |
| ENSG00000234072.1 |
Dasatinib |
Brain lower grade glioma |
0.006216642 |
Resistant |
| ENSG00000234134.1 |
Dasatinib |
Brain lower grade glioma |
0.002831242 |
Resistant |
| ENSG00000234160.1 |
Dasatinib |
Brain lower grade glioma |
0.009629418 |
Resistant |
| ENSG00000234255.4 |
Dasatinib |
Brain lower grade glioma |
0.028340614 |
Resistant |
| ENSG00000234281.1 |
Dasatinib |
Brain lower grade glioma |
0.022078319 |
Resistant |
| ENSG00000234449.2 |
Dasatinib |
Brain lower grade glioma |
0.028695455 |
Resistant |
| ENSG00000234630.1 |
Dasatinib |
Brain lower grade glioma |
0.022174951 |
Resistant |
| ENSG00000234684.2 |
Dasatinib |
Brain lower grade glioma |
0.000252659 |
Resistant |
| ENSG00000234689.1 |
Dasatinib |
Brain lower grade glioma |
0.044211249 |
Resistant |
| ENSG00000234690.2 |
Dasatinib |
Brain lower grade glioma |
0.028063032 |
Resistant |
| ENSG00000234722.3 |
Dasatinib |
Brain lower grade glioma |
0.020857107 |
Resistant |
| ENSG00000234771.2 |
Dasatinib |
Brain lower grade glioma |
0.044754105 |
Resistant |
| ENSG00000234793.1 |
Dasatinib |
Brain lower grade glioma |
0.047520569 |
Resistant |
| ENSG00000234912.5 |
Dasatinib |
Brain lower grade glioma |
0.000158157 |
Resistant |
| ENSG00000234917.1 |
Dasatinib |
Brain lower grade glioma |
0.002638688 |
Resistant |
| ENSG00000234936.1 |
Dasatinib |
Brain lower grade glioma |
0.001257431 |
Resistant |
| ENSG00000234944.1 |
Dasatinib |
Brain lower grade glioma |
0.027611235 |
Resistant |
| ENSG00000234978.1 |
Dasatinib |
Brain lower grade glioma |
0.016874104 |
Resistant |
| ENSG00000234996.3 |
Dasatinib |
Brain lower grade glioma |
0.002909432 |
Resistant |
| ENSG00000235072.1 |
Dasatinib |
Brain lower grade glioma |
0.016193016 |
Resistant |
| ENSG00000235100.3 |
Dasatinib |
Brain lower grade glioma |
0.011792992 |
Resistant |
| ENSG00000235244.3 |
Dasatinib |
Brain lower grade glioma |
0.044533775 |
Resistant |
| ENSG00000235296.1 |
Dasatinib |
Brain lower grade glioma |
0.032201951 |
Resistant |
| ENSG00000235314.1 |
Dasatinib |
Brain lower grade glioma |
0.037922252 |
Resistant |
| ENSG00000235381.1 |
Dasatinib |
Brain lower grade glioma |
0.002272124 |
Resistant |
| ENSG00000235397.1 |
Dasatinib |
Brain lower grade glioma |
0.036920034 |
Resistant |
| ENSG00000235461.1 |
Dasatinib |
Brain lower grade glioma |
0.003454615 |
Resistant |
| ENSG00000235477.2 |
Dasatinib |
Brain lower grade glioma |
0.002929012 |
Resistant |
| ENSG00000235481.2 |
Dasatinib |
Brain lower grade glioma |
0.04823611 |
Resistant |
| ENSG00000235499.1 |
Dasatinib |
Brain lower grade glioma |
0.002973517 |
Resistant |
| ENSG00000235530.2 |
Dasatinib |
Brain lower grade glioma |
0.003702762 |
Resistant |
| ENSG00000235545.1 |
Dasatinib |
Brain lower grade glioma |
0.037220078 |
Resistant |
| ENSG00000235560.3 |
Dasatinib |
Brain lower grade glioma |
0.023688769 |
Resistant |
| ENSG00000235586.1 |
Dasatinib |
Brain lower grade glioma |
0.0182597 |
Resistant |
| ENSG00000235663.1 |
Dasatinib |
Brain lower grade glioma |
0.049815452 |
Resistant |
| ENSG00000235706.3 |
Dasatinib |
Brain lower grade glioma |
0.025362253 |
Resistant |
| ENSG00000235760.3 |
Dasatinib |
Brain lower grade glioma |
0.004112271 |
Resistant |
| ENSG00000235806.1 |
Dasatinib |
Brain lower grade glioma |
0.023089249 |
Resistant |
| ENSG00000235852.1 |
Dasatinib |
Brain lower grade glioma |
0.00043237 |
Resistant |
| ENSG00000235888.1 |
Dasatinib |
Brain lower grade glioma |
0.028597624 |
Resistant |
| ENSG00000235903.3 |
Dasatinib |
Brain lower grade glioma |
0.021852146 |
Resistant |
| ENSG00000235919.3 |
Dasatinib |
Brain lower grade glioma |
0.003063769 |
Resistant |
| ENSG00000235954.2 |
Dasatinib |
Brain lower grade glioma |
0.01414277 |
Resistant |
| ENSG00000236088.5 |
Dasatinib |
Brain lower grade glioma |
0.004937257 |
Resistant |
| ENSG00000236144.2 |
Dasatinib |
Brain lower grade glioma |
0.000264932 |
Resistant |
| ENSG00000236194.2 |
Dasatinib |
Brain lower grade glioma |
0.029320599 |
Resistant |
| ENSG00000236255.1 |
Dasatinib |
Brain lower grade glioma |
0.009624932 |
Resistant |
| ENSG00000236364.2 |
Dasatinib |
Brain lower grade glioma |
0.003437454 |
Resistant |
| ENSG00000236404.4 |
Dasatinib |
Brain lower grade glioma |
0.048527133 |
Resistant |
| ENSG00000236432.3 |
Dasatinib |
Brain lower grade glioma |
0.005452861 |
Resistant |
| ENSG00000236438.2 |
Dasatinib |
Brain lower grade glioma |
0.004495179 |
Resistant |
| ENSG00000236463.1 |
Dasatinib |
Brain lower grade glioma |
0.017124521 |
Resistant |
| ENSG00000236519.1 |
Dasatinib |
Brain lower grade glioma |
0.003369298 |
Resistant |
| ENSG00000236545.1 |
Dasatinib |
Brain lower grade glioma |
0.010882083 |
Resistant |
| ENSG00000236711.2 |
Dasatinib |
Brain lower grade glioma |
0.023005745 |
Resistant |
| ENSG00000236778.3 |
Dasatinib |
Brain lower grade glioma |
0.034398007 |
Resistant |
| ENSG00000236859.2 |
Dasatinib |
Brain lower grade glioma |
0.004267853 |
Resistant |
| ENSG00000236861.2 |
Dasatinib |
Brain lower grade glioma |
0.033094724 |
Resistant |
| ENSG00000236869.1 |
Dasatinib |
Brain lower grade glioma |
0.016361094 |
Resistant |
| ENSG00000236901.3 |
Dasatinib |
Brain lower grade glioma |
0.010262161 |
Resistant |
| ENSG00000236947.1 |
Dasatinib |
Brain lower grade glioma |
0.039466767 |
Resistant |
| ENSG00000237015.1 |
Dasatinib |
Brain lower grade glioma |
0.010124284 |
Resistant |
| ENSG00000237037.5 |
Dasatinib |
Brain lower grade glioma |
0.046813932 |
Resistant |
| ENSG00000237159.1 |
Dasatinib |
Brain lower grade glioma |
0.030914153 |
Resistant |
| ENSG00000237200.1 |
Dasatinib |
Brain lower grade glioma |
0.021590178 |
Resistant |
| ENSG00000237410.1 |
Dasatinib |
Brain lower grade glioma |
0.048353512 |
Resistant |
| ENSG00000237588.2 |
Dasatinib |
Brain lower grade glioma |
0.031368858 |
Resistant |
| ENSG00000237594.2 |
Dasatinib |
Brain lower grade glioma |
0.001321002 |
Resistant |
| ENSG00000237883.1 |
Dasatinib |
Brain lower grade glioma |
0.022534099 |
Resistant |
| ENSG00000237976.1 |
Dasatinib |
Brain lower grade glioma |
0.003613441 |
Resistant |
| ENSG00000238113.2 |
Dasatinib |
Brain lower grade glioma |
0.001384035 |
Resistant |
| ENSG00000238141.2 |
Dasatinib |
Brain lower grade glioma |
0.029240946 |
Resistant |
| ENSG00000238186.1 |
Dasatinib |
Brain lower grade glioma |
0.014397586 |
Resistant |
| ENSG00000238198.1 |
Dasatinib |
Brain lower grade glioma |
0.020921084 |
Resistant |
| ENSG00000238287.1 |
Dasatinib |
Brain lower grade glioma |
0.007285726 |
Resistant |
| ENSG00000239335.4 |
Dasatinib |
Brain lower grade glioma |
0.007862202 |
Resistant |
| ENSG00000239415.1 |
Dasatinib |
Brain lower grade glioma |
0.010227346 |
Resistant |
| ENSG00000240618.1 |
Dasatinib |
Brain lower grade glioma |
0.020369151 |
Resistant |
| ENSG00000240758.2 |
Dasatinib |
Brain lower grade glioma |
0.008141632 |
Resistant |
| ENSG00000240996.1 |
Dasatinib |
Brain lower grade glioma |
0.014217618 |
Resistant |
| ENSG00000241180.1 |
Dasatinib |
Brain lower grade glioma |
0.028651049 |
Resistant |
| ENSG00000241954.1 |
Dasatinib |
Brain lower grade glioma |
0.006734198 |
Resistant |
| ENSG00000242082.1 |
Dasatinib |
Brain lower grade glioma |
0.049863665 |
Resistant |
| ENSG00000242474.1 |
Dasatinib |
Brain lower grade glioma |
0.011596962 |
Resistant |
| ENSG00000242553.1 |
Dasatinib |
Brain lower grade glioma |
0.007916659 |
Resistant |
| ENSG00000242569.3 |
Dasatinib |
Brain lower grade glioma |
0.03707643 |
Resistant |
| ENSG00000242622.1 |
Dasatinib |
Brain lower grade glioma |
0.015608917 |
Resistant |
| ENSG00000242791.2 |
Dasatinib |
Brain lower grade glioma |
0.011707252 |
Resistant |
| ENSG00000243350.1 |
Dasatinib |
Brain lower grade glioma |
0.026029731 |
Resistant |
| ENSG00000243433.1 |
Dasatinib |
Brain lower grade glioma |
0.040474389 |
Resistant |
| ENSG00000243485.2 |
Dasatinib |
Brain lower grade glioma |
0.011818313 |
Resistant |
| ENSG00000243533.2 |
Dasatinib |
Brain lower grade glioma |
0.035965278 |
Resistant |
| ENSG00000243836.1 |
Dasatinib |
Brain lower grade glioma |
0.02787049 |
Resistant |
| ENSG00000243926.1 |
Dasatinib |
Brain lower grade glioma |
0.027517439 |
Resistant |
| ENSG00000244128.1 |
Dasatinib |
Brain lower grade glioma |
0.034952029 |
Resistant |
| ENSG00000244300.2 |
Dasatinib |
Brain lower grade glioma |
0.047735726 |
Resistant |
| ENSG00000244306.5 |
Dasatinib |
Brain lower grade glioma |
0.012600244 |
Resistant |
| ENSG00000244332.1 |
Dasatinib |
Brain lower grade glioma |
0.008999918 |
Resistant |
| ENSG00000244393.3 |
Dasatinib |
Brain lower grade glioma |
0.006163367 |
Resistant |
| ENSG00000244625.1 |
Dasatinib |
Brain lower grade glioma |
0.040178091 |
Resistant |
| ENSG00000244879.3 |
Dasatinib |
Brain lower grade glioma |
0.006766669 |
Resistant |
| ENSG00000244968.2 |
Dasatinib |
Brain lower grade glioma |
0.041418941 |
Resistant |
| ENSG00000245466.1 |
Dasatinib |
Brain lower grade glioma |
0.048801145 |
Resistant |
| ENSG00000245498.2 |
Dasatinib |
Brain lower grade glioma |
0.032447399 |
Resistant |
| ENSG00000245534.2 |
Dasatinib |
Brain lower grade glioma |
0.024177628 |
Resistant |
| ENSG00000245685.2 |
Dasatinib |
Brain lower grade glioma |
0.001933596 |
Resistant |
| ENSG00000245748.1 |
Dasatinib |
Brain lower grade glioma |
0.000823926 |
Resistant |
| ENSG00000245849.2 |
Dasatinib |
Brain lower grade glioma |
0.003267643 |
Resistant |
| ENSG00000245910.4 |
Dasatinib |
Brain lower grade glioma |
0.007925645 |
Resistant |
| ENSG00000245975.2 |
Dasatinib |
Brain lower grade glioma |
0.037176664 |
Resistant |
| ENSG00000246090.2 |
Dasatinib |
Brain lower grade glioma |
0.036264334 |
Resistant |
| ENSG00000246339.4 |
Dasatinib |
Brain lower grade glioma |
0.040296254 |
Resistant |
| ENSG00000246379.2 |
Dasatinib |
Brain lower grade glioma |
0.043403816 |
Resistant |
| ENSG00000246465.1 |
Dasatinib |
Brain lower grade glioma |
0.00027807 |
Resistant |
| ENSG00000246528.3 |
Dasatinib |
Brain lower grade glioma |
0.039052423 |
Resistant |
| ENSG00000246560.2 |
Dasatinib |
Brain lower grade glioma |
0.005669428 |
Resistant |
| ENSG00000246731.2 |
Dasatinib |
Brain lower grade glioma |
0.036619196 |
Resistant |
| ENSG00000246792.2 |
Dasatinib |
Brain lower grade glioma |
0.0000065 |
Resistant |
| ENSG00000246889.2 |
Dasatinib |
Brain lower grade glioma |
0.026127563 |
Resistant |
| ENSG00000246985.3 |
Dasatinib |
Brain lower grade glioma |
0.020717275 |
Resistant |
| ENSG00000247199.3 |
Dasatinib |
Brain lower grade glioma |
0.046842858 |
Resistant |
| ENSG00000247324.2 |
Dasatinib |
Brain lower grade glioma |
0.025485056 |
Resistant |
| ENSG00000247363.2 |
Dasatinib |
Brain lower grade glioma |
0.036215176 |
Resistant |
| ENSG00000247373.2 |
Dasatinib |
Brain lower grade glioma |
0.02190007 |
Resistant |
| ENSG00000247400.3 |
Dasatinib |
Brain lower grade glioma |
0.01235875 |
Resistant |
| ENSG00000247416.2 |
Dasatinib |
Brain lower grade glioma |
0.021078315 |
Resistant |
| ENSG00000247572.3 |
Dasatinib |
Brain lower grade glioma |
0.003496049 |
Resistant |
| ENSG00000247595.2 |
Dasatinib |
Brain lower grade glioma |
0.003010654 |
Resistant |
| ENSG00000247708.3 |
Dasatinib |
Brain lower grade glioma |
0.000701337 |
Resistant |
| ENSG00000247877.2 |
Dasatinib |
Brain lower grade glioma |
0.048648995 |
Resistant |
| ENSG00000247950.2 |
Dasatinib |
Brain lower grade glioma |
0.009141469 |
Resistant |
| ENSG00000248175.1 |
Dasatinib |
Brain lower grade glioma |
0.005089889 |
Resistant |
| ENSG00000248240.1 |
Dasatinib |
Brain lower grade glioma |
0.003072327 |
Resistant |
| ENSG00000248256.1 |
Dasatinib |
Brain lower grade glioma |
0.012011722 |
Resistant |
| ENSG00000248367.1 |
Dasatinib |
Brain lower grade glioma |
0.036336326 |
Resistant |
| ENSG00000248445.1 |
Dasatinib |
Brain lower grade glioma |
0.032650637 |
Resistant |
| ENSG00000248476.1 |
Dasatinib |
Brain lower grade glioma |
0.013396068 |
Resistant |
| ENSG00000248508.2 |
Dasatinib |
Brain lower grade glioma |
0.003918045 |
Resistant |
| ENSG00000248576.1 |
Dasatinib |
Brain lower grade glioma |
0.044104722 |
Resistant |
| ENSG00000248671.3 |
Dasatinib |
Brain lower grade glioma |
0.000174102 |
Resistant |
| ENSG00000248774.1 |
Dasatinib |
Brain lower grade glioma |
0.015537104 |
Resistant |
| ENSG00000248932.1 |
Dasatinib |
Brain lower grade glioma |
0.023374619 |
Resistant |
| ENSG00000249234.1 |
Dasatinib |
Brain lower grade glioma |
0.028009893 |
Resistant |
| ENSG00000249348.1 |
Dasatinib |
Brain lower grade glioma |
0.007768346 |
Resistant |
| ENSG00000249494.1 |
Dasatinib |
Brain lower grade glioma |
0.018382038 |
Resistant |
| ENSG00000249592.1 |
Dasatinib |
Brain lower grade glioma |
0.018655664 |
Resistant |
| ENSG00000249602.1 |
Dasatinib |
Brain lower grade glioma |
0.013715051 |
Resistant |
| ENSG00000249635.1 |
Dasatinib |
Brain lower grade glioma |
0.001704473 |
Resistant |
| ENSG00000249655.1 |
Dasatinib |
Brain lower grade glioma |
0.033473677 |
Resistant |
| ENSG00000249846.2 |
Dasatinib |
Brain lower grade glioma |
0.014776883 |
Resistant |
| ENSG00000249870.1 |
Dasatinib |
Brain lower grade glioma |
0.01548298 |
Resistant |
| ENSG00000250015.1 |
Dasatinib |
Brain lower grade glioma |
0.014904464 |
Resistant |
| ENSG00000250027.1 |
Dasatinib |
Brain lower grade glioma |
0.021133634 |
Resistant |
| ENSG00000250039.3 |
Dasatinib |
Brain lower grade glioma |
0.007507866 |
Resistant |
| ENSG00000250107.1 |
Dasatinib |
Brain lower grade glioma |
0.044234683 |
Resistant |
| ENSG00000250116.2 |
Dasatinib |
Brain lower grade glioma |
0.019849752 |
Resistant |
| ENSG00000250132.2 |
Dasatinib |
Brain lower grade glioma |
0.010906395 |
Resistant |
| ENSG00000250220.1 |
Dasatinib |
Brain lower grade glioma |
0.001887683 |
Resistant |
| ENSG00000250365.2 |
Dasatinib |
Brain lower grade glioma |
0.021475846 |
Resistant |
| ENSG00000250616.2 |
Dasatinib |
Brain lower grade glioma |
0.027858257 |
Resistant |
| ENSG00000250765.1 |
Dasatinib |
Brain lower grade glioma |
0.012860659 |
Resistant |
| ENSG00000250802.2 |
Dasatinib |
Brain lower grade glioma |
0.000958985 |
Resistant |
| ENSG00000250910.3 |
Dasatinib |
Brain lower grade glioma |
0.04254698 |
Resistant |
| ENSG00000250986.1 |
Dasatinib |
Brain lower grade glioma |
0.034799301 |
Resistant |
| ENSG00000251022.2 |
Dasatinib |
Brain lower grade glioma |
0.006843957 |
Resistant |
| ENSG00000251141.1 |
Dasatinib |
Brain lower grade glioma |
0.033822497 |
Resistant |
| ENSG00000251175.1 |
Dasatinib |
Brain lower grade glioma |
0.04540653 |
Resistant |
| ENSG00000251259.1 |
Dasatinib |
Brain lower grade glioma |
0.001816745 |
Resistant |
| ENSG00000251323.2 |
Dasatinib |
Brain lower grade glioma |
0.012937612 |
Resistant |
| ENSG00000251523.1 |
Dasatinib |
Brain lower grade glioma |
0.012360803 |
Resistant |
| ENSG00000251555.1 |
Dasatinib |
Brain lower grade glioma |
0.026396465 |
Resistant |
| ENSG00000251666.1 |
Dasatinib |
Brain lower grade glioma |
0.004684275 |
Resistant |
| ENSG00000253106.1 |
Dasatinib |
Brain lower grade glioma |
0.006890442 |
Resistant |
| ENSG00000253307.1 |
Dasatinib |
Brain lower grade glioma |
0.04496239 |
Resistant |
| ENSG00000253352.4 |
Dasatinib |
Brain lower grade glioma |
0.004871299 |
Resistant |
| ENSG00000253477.1 |
Dasatinib |
Brain lower grade glioma |
0.033851042 |
Resistant |
| ENSG00000253509.1 |
Dasatinib |
Brain lower grade glioma |
0.045211893 |
Resistant |
| ENSG00000253559.1 |
Dasatinib |
Brain lower grade glioma |
0.026403315 |
Resistant |
| ENSG00000253696.2 |
Dasatinib |
Brain lower grade glioma |
0.014834624 |
Resistant |
| ENSG00000253704.1 |
Dasatinib |
Brain lower grade glioma |
0.004944257 |
Resistant |
| ENSG00000253854.1 |
Dasatinib |
Brain lower grade glioma |
0.000108947 |
Resistant |
| ENSG00000253865.1 |
Dasatinib |
Brain lower grade glioma |
0.043776876 |
Resistant |
| ENSG00000253961.1 |
Dasatinib |
Brain lower grade glioma |
0.030930711 |
Resistant |
| ENSG00000253986.1 |
Dasatinib |
Brain lower grade glioma |
0.035404556 |
Resistant |
| ENSG00000254165.1 |
Dasatinib |
Brain lower grade glioma |
0.020744515 |
Resistant |
| ENSG00000254192.1 |
Dasatinib |
Brain lower grade glioma |
0.032565958 |
Resistant |
| ENSG00000254207.1 |
Dasatinib |
Brain lower grade glioma |
0.029813725 |
Resistant |
| ENSG00000254266.1 |
Dasatinib |
Brain lower grade glioma |
0.020366991 |
Resistant |
| ENSG00000254370.1 |
Dasatinib |
Brain lower grade glioma |
0.007950674 |
Resistant |
| ENSG00000254468.1 |
Dasatinib |
Brain lower grade glioma |
0.042135627 |
Resistant |
| ENSG00000254602.1 |
Dasatinib |
Brain lower grade glioma |
0.040153875 |
Resistant |
| ENSG00000254691.1 |
Dasatinib |
Brain lower grade glioma |
0.004074365 |
Resistant |
| ENSG00000254812.1 |
Dasatinib |
Brain lower grade glioma |
0.021155084 |
Resistant |
| ENSG00000254966.1 |
Dasatinib |
Brain lower grade glioma |
0.026352322 |
Resistant |
| ENSG00000255100.1 |
Dasatinib |
Brain lower grade glioma |
0.023976638 |
Resistant |
| ENSG00000255306.1 |
Dasatinib |
Brain lower grade glioma |
0.015760012 |
Resistant |
| ENSG00000255326.1 |
Dasatinib |
Brain lower grade glioma |
0.022927644 |
Resistant |
| ENSG00000255334.1 |
Dasatinib |
Brain lower grade glioma |
0.030097 |
Resistant |
| ENSG00000255434.1 |
Dasatinib |
Brain lower grade glioma |
0.022295852 |
Resistant |
| ENSG00000255458.1 |
Dasatinib |
Brain lower grade glioma |
0.005316972 |
Resistant |
| ENSG00000255559.1 |
Dasatinib |
Brain lower grade glioma |
0.000604119 |
Resistant |
| ENSG00000255571.2 |
Dasatinib |
Brain lower grade glioma |
0.014308573 |
Resistant |
| ENSG00000255670.1 |
Dasatinib |
Brain lower grade glioma |
0.001102984 |
Resistant |
| ENSG00000255843.1 |
Dasatinib |
Brain lower grade glioma |
0.005802328 |
Resistant |
| ENSG00000255857.1 |
Dasatinib |
Brain lower grade glioma |
0.035042303 |
Resistant |
| ENSG00000255933.1 |
Dasatinib |
Brain lower grade glioma |
0.042581722 |
Resistant |
| ENSG00000255966.1 |
Dasatinib |
Brain lower grade glioma |
0.017104864 |
Resistant |
| ENSG00000256196.1 |
Dasatinib |
Brain lower grade glioma |
0.001374887 |
Resistant |
| ENSG00000256250.1 |
Dasatinib |
Brain lower grade glioma |
0.0356436 |
Resistant |
| ENSG00000256278.1 |
Dasatinib |
Brain lower grade glioma |
0.015840869 |
Resistant |
| ENSG00000256360.1 |
Dasatinib |
Brain lower grade glioma |
0.020032169 |
Resistant |
| ENSG00000256712.1 |
Dasatinib |
Brain lower grade glioma |
0.030079105 |
Resistant |
| ENSG00000256747.1 |
Dasatinib |
Brain lower grade glioma |
0.046906984 |
Resistant |
| ENSG00000257023.1 |
Dasatinib |
Brain lower grade glioma |
0.031793568 |
Resistant |
| ENSG00000257151.1 |
Dasatinib |
Brain lower grade glioma |
0.036721255 |
Resistant |
| ENSG00000257176.1 |
Dasatinib |
Brain lower grade glioma |
0.021557103 |
Resistant |
| ENSG00000257270.1 |
Dasatinib |
Brain lower grade glioma |
0.03119449 |
Resistant |
| ENSG00000257534.1 |
Dasatinib |
Brain lower grade glioma |
0.008078471 |
Resistant |
| ENSG00000257647.1 |
Dasatinib |
Brain lower grade glioma |
0.031834609 |
Resistant |
| ENSG00000257660.1 |
Dasatinib |
Brain lower grade glioma |
0.014912984 |
Resistant |
| ENSG00000257815.1 |
Dasatinib |
Brain lower grade glioma |
0.046700749 |
Resistant |
| ENSG00000257817.1 |
Dasatinib |
Brain lower grade glioma |
0.044543926 |
Resistant |
| ENSG00000257964.1 |
Dasatinib |
Brain lower grade glioma |
0.000596916 |
Resistant |
| ENSG00000258199.1 |
Dasatinib |
Brain lower grade glioma |
0.003249422 |
Resistant |
| ENSG00000258285.1 |
Dasatinib |
Brain lower grade glioma |
0.045780499 |
Resistant |
| ENSG00000258301.2 |
Dasatinib |
Brain lower grade glioma |
0.003039055 |
Resistant |
| ENSG00000258344.1 |
Dasatinib |
Brain lower grade glioma |
0.021711909 |
Resistant |
| ENSG00000258441.1 |
Dasatinib |
Brain lower grade glioma |
0.042377475 |
Resistant |
| ENSG00000258450.1 |
Dasatinib |
Brain lower grade glioma |
0.026469588 |
Resistant |
| ENSG00000258515.1 |
Dasatinib |
Brain lower grade glioma |
0.045277877 |
Resistant |
| ENSG00000258520.1 |
Dasatinib |
Brain lower grade glioma |
0.010666922 |
Resistant |
| ENSG00000258525.1 |
Dasatinib |
Brain lower grade glioma |
0.028564275 |
Resistant |
| ENSG00000258682.1 |
Dasatinib |
Brain lower grade glioma |
0.041334285 |
Resistant |
| ENSG00000258748.1 |
Dasatinib |
Brain lower grade glioma |
0.034993881 |
Resistant |
| ENSG00000258789.1 |
Dasatinib |
Brain lower grade glioma |
0.025002684 |
Resistant |
| ENSG00000258957.1 |
Dasatinib |
Brain lower grade glioma |
0.022648574 |
Resistant |
| ENSG00000259153.1 |
Dasatinib |
Brain lower grade glioma |
0.00388047 |
Resistant |
| ENSG00000259172.1 |
Dasatinib |
Brain lower grade glioma |
0.015417895 |
Resistant |
| ENSG00000259182.1 |
Dasatinib |
Brain lower grade glioma |
0.032901996 |
Resistant |
| ENSG00000259206.1 |
Dasatinib |
Brain lower grade glioma |
0.021418457 |
Resistant |
| ENSG00000259242.2 |
Dasatinib |
Brain lower grade glioma |
0.013019969 |
Resistant |
| ENSG00000259264.1 |
Dasatinib |
Brain lower grade glioma |
0.002060741 |
Resistant |
| ENSG00000259310.1 |
Dasatinib |
Brain lower grade glioma |
0.043126015 |
Resistant |
| ENSG00000259366.1 |
Dasatinib |
Brain lower grade glioma |
0.036952699 |
Resistant |
| ENSG00000259416.2 |
Dasatinib |
Brain lower grade glioma |
0.046274094 |
Resistant |
| ENSG00000259442.1 |
Dasatinib |
Brain lower grade glioma |
0.007099874 |
Resistant |
| ENSG00000259448.2 |
Dasatinib |
Brain lower grade glioma |
0.004525433 |
Resistant |
| ENSG00000259488.1 |
Dasatinib |
Brain lower grade glioma |
0.017456806 |
Resistant |
| ENSG00000259548.1 |
Dasatinib |
Brain lower grade glioma |
0.007299224 |
Resistant |
| ENSG00000259553.2 |
Dasatinib |
Brain lower grade glioma |
0.012214667 |
Resistant |
| ENSG00000259606.2 |
Dasatinib |
Brain lower grade glioma |
0.043786233 |
Resistant |
| ENSG00000259623.1 |
Dasatinib |
Brain lower grade glioma |
0.0045887 |
Resistant |
| ENSG00000259668.1 |
Dasatinib |
Brain lower grade glioma |
0.038788079 |
Resistant |
| ENSG00000259673.1 |
Dasatinib |
Brain lower grade glioma |
0.001186504 |
Resistant |
| ENSG00000259715.1 |
Dasatinib |
Brain lower grade glioma |
0.015012676 |
Resistant |
| ENSG00000259762.1 |
Dasatinib |
Brain lower grade glioma |
0.021781302 |
Resistant |
| ENSG00000259772.2 |
Dasatinib |
Brain lower grade glioma |
0.012979811 |
Resistant |
| ENSG00000259793.1 |
Dasatinib |
Brain lower grade glioma |
0.048329283 |
Resistant |
| ENSG00000259877.1 |
Dasatinib |
Brain lower grade glioma |
0.026020146 |
Resistant |
| ENSG00000259891.1 |
Dasatinib |
Brain lower grade glioma |
0.028285103 |
Resistant |
| ENSG00000259953.1 |
Dasatinib |
Brain lower grade glioma |
0.049325475 |
Resistant |
| ENSG00000259954.1 |
Dasatinib |
Brain lower grade glioma |
0.028295269 |
Resistant |
| ENSG00000259994.1 |
Dasatinib |
Brain lower grade glioma |
0.024796022 |
Resistant |
| ENSG00000260084.1 |
Dasatinib |
Brain lower grade glioma |
0.039647552 |
Resistant |
| ENSG00000260091.1 |
Dasatinib |
Brain lower grade glioma |
0.00244358 |
Resistant |
| ENSG00000260095.1 |
Dasatinib |
Brain lower grade glioma |
0.010744212 |
Resistant |
| ENSG00000260163.1 |
Dasatinib |
Brain lower grade glioma |
0.038242645 |
Resistant |
| ENSG00000260167.1 |
Dasatinib |
Brain lower grade glioma |
0.0000744 |
Resistant |
| ENSG00000260176.1 |
Dasatinib |
Brain lower grade glioma |
0.007391226 |
Resistant |
| ENSG00000260186.1 |
Dasatinib |
Brain lower grade glioma |
0.036626804 |
Resistant |
| ENSG00000260196.1 |
Dasatinib |
Brain lower grade glioma |
0.018861802 |
Resistant |
| ENSG00000260233.2 |
Dasatinib |
Brain lower grade glioma |
0.013959254 |
Resistant |
| ENSG00000260248.1 |
Dasatinib |
Brain lower grade glioma |
0.007620116 |
Resistant |
| ENSG00000260261.1 |
Dasatinib |
Brain lower grade glioma |
0.000349197 |
Resistant |
| ENSG00000260269.1 |
Dasatinib |
Brain lower grade glioma |
0.003895658 |
Resistant |
| ENSG00000260276.1 |
Dasatinib |
Brain lower grade glioma |
0.020470685 |
Resistant |
| ENSG00000260277.1 |
Dasatinib |
Brain lower grade glioma |
0.007112064 |
Resistant |
| ENSG00000260285.1 |
Dasatinib |
Brain lower grade glioma |
0.009280735 |
Resistant |
| ENSG00000260293.1 |
Dasatinib |
Brain lower grade glioma |
0.001287373 |
Resistant |
| ENSG00000260296.1 |
Dasatinib |
Brain lower grade glioma |
0.010920422 |
Resistant |
| ENSG00000260306.1 |
Dasatinib |
Brain lower grade glioma |
0.012218471 |
Resistant |
| ENSG00000260361.1 |
Dasatinib |
Brain lower grade glioma |
0.0136669 |
Resistant |
| ENSG00000260381.2 |
Dasatinib |
Brain lower grade glioma |
0.041738111 |
Resistant |
| ENSG00000260388.1 |
Dasatinib |
Brain lower grade glioma |
0.011566846 |
Resistant |
| ENSG00000260400.1 |
Dasatinib |
Brain lower grade glioma |
0.021471887 |
Resistant |
| ENSG00000260404.2 |
Dasatinib |
Brain lower grade glioma |
0.044263297 |
Resistant |
| ENSG00000260411.2 |
Dasatinib |
Brain lower grade glioma |
0.026424434 |
Resistant |
| ENSG00000260425.1 |
Dasatinib |
Brain lower grade glioma |
0.043325726 |
Resistant |
| ENSG00000260515.1 |
Dasatinib |
Brain lower grade glioma |
0.023153496 |
Resistant |
| ENSG00000260572.1 |
Dasatinib |
Brain lower grade glioma |
0.04057355 |
Resistant |
| ENSG00000260583.1 |
Dasatinib |
Brain lower grade glioma |
0.026090553 |
Resistant |
| ENSG00000260608.1 |
Dasatinib |
Brain lower grade glioma |
0.035191458 |
Resistant |
| ENSG00000260626.1 |
Dasatinib |
Brain lower grade glioma |
0.034365169 |
Resistant |
| ENSG00000260646.1 |
Dasatinib |
Brain lower grade glioma |
0.003573633 |
Resistant |
| ENSG00000260671.1 |
Dasatinib |
Brain lower grade glioma |
0.024902058 |
Resistant |
| ENSG00000260708.1 |
Dasatinib |
Brain lower grade glioma |
0.012345415 |
Resistant |
| ENSG00000260743.1 |
Dasatinib |
Brain lower grade glioma |
0.026532485 |
Resistant |
| ENSG00000260751.2 |
Dasatinib |
Brain lower grade glioma |
0.044828764 |
Resistant |
| ENSG00000260804.2 |
Dasatinib |
Brain lower grade glioma |
0.046345545 |
Resistant |
| ENSG00000260837.1 |
Dasatinib |
Brain lower grade glioma |
0.030501062 |
Resistant |
| ENSG00000260853.1 |
Dasatinib |
Brain lower grade glioma |
0.010393084 |
Resistant |
| ENSG00000260871.1 |
Dasatinib |
Brain lower grade glioma |
0.008216068 |
Resistant |
| ENSG00000260874.1 |
Dasatinib |
Brain lower grade glioma |
0.002792318 |
Resistant |
| ENSG00000260884.1 |
Dasatinib |
Brain lower grade glioma |
0.038841056 |
Resistant |
| ENSG00000260917.1 |
Dasatinib |
Brain lower grade glioma |
0.025699419 |
Resistant |
| ENSG00000260942.1 |
Dasatinib |
Brain lower grade glioma |
0.008788928 |
Resistant |
| ENSG00000260947.1 |
Dasatinib |
Brain lower grade glioma |
0.028750936 |
Resistant |
| ENSG00000260949.1 |
Dasatinib |
Brain lower grade glioma |
0.012284596 |
Resistant |
| ENSG00000260973.1 |
Dasatinib |
Brain lower grade glioma |
0.026822517 |
Resistant |
| ENSG00000261005.1 |
Dasatinib |
Brain lower grade glioma |
0.008816085 |
Resistant |
| ENSG00000261024.2 |
Dasatinib |
Brain lower grade glioma |
0.031305749 |
Resistant |
| ENSG00000261096.1 |
Dasatinib |
Brain lower grade glioma |
0.003633482 |
Resistant |
| ENSG00000261124.1 |
Dasatinib |
Brain lower grade glioma |
0.033472984 |
Resistant |
| ENSG00000261140.1 |
Dasatinib |
Brain lower grade glioma |
0.001148827 |
Resistant |
| ENSG00000261141.1 |
Dasatinib |
Brain lower grade glioma |
0.016804984 |
Resistant |
| ENSG00000261159.1 |
Dasatinib |
Brain lower grade glioma |
0.018384451 |
Resistant |
| ENSG00000261167.1 |
Dasatinib |
Brain lower grade glioma |
0.00036479 |
Resistant |
| ENSG00000261168.1 |
Dasatinib |
Brain lower grade glioma |
0.036490527 |
Resistant |
| ENSG00000261188.1 |
Dasatinib |
Brain lower grade glioma |
0.012099994 |
Resistant |
| ENSG00000261200.1 |
Dasatinib |
Brain lower grade glioma |
0.019693027 |
Resistant |
| ENSG00000261216.1 |
Dasatinib |
Brain lower grade glioma |
0.005315302 |
Resistant |
| ENSG00000261251.1 |
Dasatinib |
Brain lower grade glioma |
0.04310334 |
Resistant |
| ENSG00000261288.1 |
Dasatinib |
Brain lower grade glioma |
0.002981843 |
Resistant |
| ENSG00000261355.1 |
Dasatinib |
Brain lower grade glioma |
0.020832114 |
Resistant |
| ENSG00000261366.1 |
Dasatinib |
Brain lower grade glioma |
0.048552684 |
Resistant |
| ENSG00000261372.1 |
Dasatinib |
Brain lower grade glioma |
0.048007016 |
Resistant |
| ENSG00000261399.1 |
Dasatinib |
Brain lower grade glioma |
0.044265775 |
Resistant |
| ENSG00000261420.1 |
Dasatinib |
Brain lower grade glioma |
0.020470383 |
Resistant |
| ENSG00000261428.1 |
Dasatinib |
Brain lower grade glioma |
0.014502777 |
Resistant |
| ENSG00000261474.1 |
Dasatinib |
Brain lower grade glioma |
0.045875165 |
Resistant |
| ENSG00000261476.1 |
Dasatinib |
Brain lower grade glioma |
0.010771663 |
Resistant |
| ENSG00000261496.1 |
Dasatinib |
Brain lower grade glioma |
0.031838547 |
Resistant |
| ENSG00000261526.1 |
Dasatinib |
Brain lower grade glioma |
0.031349228 |
Resistant |
| ENSG00000261533.1 |
Dasatinib |
Brain lower grade glioma |
0.004185406 |
Resistant |
| ENSG00000261542.1 |
Dasatinib |
Brain lower grade glioma |
0.018814867 |
Resistant |
| ENSG00000261570.1 |
Dasatinib |
Brain lower grade glioma |
0.047180848 |
Resistant |
| ENSG00000261578.1 |
Dasatinib |
Brain lower grade glioma |
0.002237628 |
Resistant |
| ENSG00000261589.1 |
Dasatinib |
Brain lower grade glioma |
0.024895083 |
Resistant |
| ENSG00000261596.1 |
Dasatinib |
Brain lower grade glioma |
0.036367358 |
Resistant |
| ENSG00000261597.1 |
Dasatinib |
Brain lower grade glioma |
0.037245341 |
Resistant |
| ENSG00000261613.2 |
Dasatinib |
Brain lower grade glioma |
0.005843056 |
Resistant |
| ENSG00000261632.1 |
Dasatinib |
Brain lower grade glioma |
0.008977304 |
Resistant |
| ENSG00000261663.1 |
Dasatinib |
Brain lower grade glioma |
0.016285585 |
Resistant |
| ENSG00000261670.1 |
Dasatinib |
Brain lower grade glioma |
0.008245497 |
Resistant |
| ENSG00000261731.2 |
Dasatinib |
Brain lower grade glioma |
0.017648707 |
Resistant |
| ENSG00000261744.1 |
Dasatinib |
Brain lower grade glioma |
0.007503106 |
Resistant |
| ENSG00000261770.1 |
Dasatinib |
Brain lower grade glioma |
0.046543855 |
Resistant |
| ENSG00000261775.1 |
Dasatinib |
Brain lower grade glioma |
0.00416884 |
Resistant |
| ENSG00000261777.1 |
Dasatinib |
Brain lower grade glioma |
0.029683849 |
Resistant |
| ENSG00000261799.1 |
Dasatinib |
Brain lower grade glioma |
0.0000678 |
Resistant |
| ENSG00000261840.1 |
Dasatinib |
Brain lower grade glioma |
0.008022384 |
Resistant |
| ENSG00000261879.1 |
Dasatinib |
Brain lower grade glioma |
0.02265041 |
Resistant |
| ENSG00000261886.1 |
Dasatinib |
Brain lower grade glioma |
0.012428137 |
Resistant |
| ENSG00000261916.1 |
Dasatinib |
Brain lower grade glioma |
0.03687196 |
Resistant |
| ENSG00000261924.1 |
Dasatinib |
Brain lower grade glioma |
0.001409736 |
Resistant |
| ENSG00000262119.1 |
Dasatinib |
Brain lower grade glioma |
0.019985957 |
Resistant |
| ENSG00000262222.1 |
Dasatinib |
Brain lower grade glioma |
0.015864097 |
Resistant |
| ENSG00000262410.1 |
Dasatinib |
Brain lower grade glioma |
0.015746328 |
Resistant |
| ENSG00000262580.1 |
Dasatinib |
Brain lower grade glioma |
0.004449799 |
Resistant |
| ENSG00000262652.1 |
Dasatinib |
Brain lower grade glioma |
0.025641803 |
Resistant |
| ENSG00000262703.1 |
Dasatinib |
Brain lower grade glioma |
0.021085806 |
Resistant |
| ENSG00000262766.1 |
Dasatinib |
Brain lower grade glioma |
0.018033255 |
Resistant |
| ENSG00000262837.1 |
Dasatinib |
Brain lower grade glioma |
0.009636023 |
Resistant |
| ENSG00000262879.1 |
Dasatinib |
Brain lower grade glioma |
0.010102427 |
Resistant |
| ENSG00000262951.1 |
Dasatinib |
Brain lower grade glioma |
0.025960278 |
Resistant |
| ENSG00000263013.1 |
Dasatinib |
Brain lower grade glioma |
0.027395299 |
Resistant |
| ENSG00000263069.1 |
Dasatinib |
Brain lower grade glioma |
0.012964798 |
Resistant |
| ENSG00000263072.1 |
Dasatinib |
Brain lower grade glioma |
0.016344268 |
Resistant |
| ENSG00000263080.1 |
Dasatinib |
Brain lower grade glioma |
0.010958265 |
Resistant |
| ENSG00000263220.1 |
Dasatinib |
Brain lower grade glioma |
0.014630204 |
Resistant |
| ENSG00000263272.1 |
Dasatinib |
Brain lower grade glioma |
0.021398714 |
Resistant |
| ENSG00000263307.1 |
Dasatinib |
Brain lower grade glioma |
0.027922058 |
Resistant |
| ENSG00000263350.1 |
Dasatinib |
Brain lower grade glioma |
0.002042126 |
Resistant |
| ENSG00000263412.1 |
Dasatinib |
Brain lower grade glioma |
0.011384108 |
Resistant |
| ENSG00000263531.1 |
Dasatinib |
Brain lower grade glioma |
0.036296211 |
Resistant |
| ENSG00000263603.1 |
Dasatinib |
Brain lower grade glioma |
0.007342829 |
Resistant |
| ENSG00000263731.1 |
Dasatinib |
Brain lower grade glioma |
0.001034046 |
Resistant |
| ENSG00000263766.1 |
Dasatinib |
Brain lower grade glioma |
0.019020878 |
Resistant |
| ENSG00000263786.1 |
Dasatinib |
Brain lower grade glioma |
0.011932457 |
Resistant |
| ENSG00000263847.1 |
Dasatinib |
Brain lower grade glioma |
0.043306173 |
Resistant |
| ENSG00000263859.1 |
Dasatinib |
Brain lower grade glioma |
0.001935042 |
Resistant |
| ENSG00000263884.1 |
Dasatinib |
Brain lower grade glioma |
0.022229927 |
Resistant |
| ENSG00000264167.1 |
Dasatinib |
Brain lower grade glioma |
0.035610979 |
Resistant |
| ENSG00000264247.1 |
Dasatinib |
Brain lower grade glioma |
0.002453318 |
Resistant |
| ENSG00000264270.1 |
Dasatinib |
Brain lower grade glioma |
0.039104644 |
Resistant |
| ENSG00000264304.1 |
Dasatinib |
Brain lower grade glioma |
0.034119421 |
Resistant |
| ENSG00000264491.1 |
Dasatinib |
Brain lower grade glioma |
0.037137146 |
Resistant |
| ENSG00000264520.1 |
Dasatinib |
Brain lower grade glioma |
0.032757074 |
Resistant |
| ENSG00000264548.1 |
Dasatinib |
Brain lower grade glioma |
0.010568617 |
Resistant |
| ENSG00000264608.1 |
Dasatinib |
Brain lower grade glioma |
0.04783533 |
Resistant |
| ENSG00000264769.1 |
Dasatinib |
Brain lower grade glioma |
0.040035099 |
Resistant |
| ENSG00000264853.1 |
Dasatinib |
Brain lower grade glioma |
0.025298613 |
Resistant |
| ENSG00000264860.1 |
Dasatinib |
Brain lower grade glioma |
0.00520331 |
Resistant |
| ENSG00000264885.1 |
Dasatinib |
Brain lower grade glioma |
0.030123547 |
Resistant |
| ENSG00000264895.1 |
Dasatinib |
Brain lower grade glioma |
0.008553853 |
Resistant |
| ENSG00000264937.1 |
Dasatinib |
Brain lower grade glioma |
0.012410658 |
Resistant |
| ENSG00000265218.1 |
Dasatinib |
Brain lower grade glioma |
0.006821877 |
Resistant |
| ENSG00000265242.1 |
Dasatinib |
Brain lower grade glioma |
0.002653757 |
Resistant |
| ENSG00000265443.1 |
Dasatinib |
Brain lower grade glioma |
0.003460873 |
Resistant |
| ENSG00000265692.1 |
Dasatinib |
Brain lower grade glioma |
0.016597768 |
Resistant |
| ENSG00000265749.1 |
Dasatinib |
Brain lower grade glioma |
0.034831637 |
Resistant |
| ENSG00000265791.1 |
Dasatinib |
Brain lower grade glioma |
0.004838291 |
Resistant |
| ENSG00000265800.1 |
Dasatinib |
Brain lower grade glioma |
0.013707994 |
Resistant |
| ENSG00000265845.2 |
Dasatinib |
Brain lower grade glioma |
0.018953287 |
Resistant |
| ENSG00000266040.1 |
Dasatinib |
Brain lower grade glioma |
0.021594909 |
Resistant |
| ENSG00000266236.1 |
Dasatinib |
Brain lower grade glioma |
0.042085681 |
Resistant |
| ENSG00000266261.1 |
Dasatinib |
Brain lower grade glioma |
0.004211484 |
Resistant |
| ENSG00000266289.1 |
Dasatinib |
Brain lower grade glioma |
0.034836708 |
Resistant |
| ENSG00000266313.1 |
Dasatinib |
Brain lower grade glioma |
0.016814973 |
Resistant |
| ENSG00000266904.1 |
Dasatinib |
Brain lower grade glioma |
0.026865317 |
Resistant |
| ENSG00000266916.1 |
Dasatinib |
Brain lower grade glioma |
0.044096156 |
Resistant |
| ENSG00000266918.1 |
Dasatinib |
Brain lower grade glioma |
0.014240468 |
Resistant |
| ENSG00000266935.1 |
Dasatinib |
Brain lower grade glioma |
0.038250971 |
Resistant |
| ENSG00000266942.1 |
Dasatinib |
Brain lower grade glioma |
0.019820228 |
Resistant |
| ENSG00000267002.1 |
Dasatinib |
Brain lower grade glioma |
0.00016326 |
Resistant |
| ENSG00000267006.1 |
Dasatinib |
Brain lower grade glioma |
0.041324213 |
Resistant |
| ENSG00000267011.1 |
Dasatinib |
Brain lower grade glioma |
0.021634291 |
Resistant |
| ENSG00000267040.2 |
Dasatinib |
Brain lower grade glioma |
0.010363847 |
Resistant |
| ENSG00000267053.2 |
Dasatinib |
Brain lower grade glioma |
0.002619326 |
Resistant |
| ENSG00000267100.1 |
Dasatinib |
Brain lower grade glioma |
0.022703936 |
Resistant |
| ENSG00000267115.1 |
Dasatinib |
Brain lower grade glioma |
0.014653226 |
Resistant |
| ENSG00000267131.1 |
Dasatinib |
Brain lower grade glioma |
0.04304094 |
Resistant |
| ENSG00000267152.1 |
Dasatinib |
Brain lower grade glioma |
0.0000569 |
Resistant |
| ENSG00000267159.1 |
Dasatinib |
Brain lower grade glioma |
0.043552965 |
Resistant |
| ENSG00000267167.1 |
Dasatinib |
Brain lower grade glioma |
0.003486523 |
Resistant |
| ENSG00000267194.1 |
Dasatinib |
Brain lower grade glioma |
0.039046567 |
Resistant |
| ENSG00000267198.1 |
Dasatinib |
Brain lower grade glioma |
0.023994373 |
Resistant |
| ENSG00000267212.1 |
Dasatinib |
Brain lower grade glioma |
0.014842272 |
Resistant |
| ENSG00000267221.1 |
Dasatinib |
Brain lower grade glioma |
0.015197872 |
Resistant |
| ENSG00000267232.1 |
Dasatinib |
Brain lower grade glioma |
0.028355427 |
Resistant |
| ENSG00000267246.1 |
Dasatinib |
Brain lower grade glioma |
0.011489186 |
Resistant |
| ENSG00000267248.1 |
Dasatinib |
Brain lower grade glioma |
0.008912864 |
Resistant |
| ENSG00000267254.1 |
Dasatinib |
Brain lower grade glioma |
0.004538061 |
Resistant |
| ENSG00000267280.1 |
Dasatinib |
Brain lower grade glioma |
0.030919105 |
Resistant |
| ENSG00000267296.2 |
Dasatinib |
Brain lower grade glioma |
0.041182619 |
Resistant |
| ENSG00000267345.1 |
Dasatinib |
Brain lower grade glioma |
0.045620847 |
Resistant |
| ENSG00000267347.1 |
Dasatinib |
Brain lower grade glioma |
0.009513587 |
Resistant |
| ENSG00000267348.2 |
Dasatinib |
Brain lower grade glioma |
0.020165093 |
Resistant |
| ENSG00000267388.1 |
Dasatinib |
Brain lower grade glioma |
0.033900086 |
Resistant |
| ENSG00000267419.1 |
Dasatinib |
Brain lower grade glioma |
0.001832365 |
Resistant |
| ENSG00000267470.1 |
Dasatinib |
Brain lower grade glioma |
0.037572584 |
Resistant |
| ENSG00000267474.1 |
Dasatinib |
Brain lower grade glioma |
0.013408365 |
Resistant |
| ENSG00000267481.1 |
Dasatinib |
Brain lower grade glioma |
0.009873734 |
Resistant |
| ENSG00000267581.1 |
Dasatinib |
Brain lower grade glioma |
0.021483266 |
Resistant |
| ENSG00000267605.1 |
Dasatinib |
Brain lower grade glioma |
0.034600509 |
Resistant |
| ENSG00000267651.1 |
Dasatinib |
Brain lower grade glioma |
0.049460827 |
Resistant |
| ENSG00000267682.1 |
Dasatinib |
Brain lower grade glioma |
0.049709863 |
Resistant |
| ENSG00000267715.1 |
Dasatinib |
Brain lower grade glioma |
0.042294943 |
Resistant |
| ENSG00000267730.1 |
Dasatinib |
Brain lower grade glioma |
0.049767416 |
Resistant |
| ENSG00000267750.1 |
Dasatinib |
Brain lower grade glioma |
0.029062123 |
Resistant |
| ENSG00000267758.1 |
Dasatinib |
Brain lower grade glioma |
0.004784499 |
Resistant |
| ENSG00000267765.1 |
Dasatinib |
Brain lower grade glioma |
0.01021018 |
Resistant |
| ENSG00000267767.2 |
Dasatinib |
Brain lower grade glioma |
0.035723612 |
Resistant |
| ENSG00000267778.1 |
Dasatinib |
Brain lower grade glioma |
0.012202049 |
Resistant |
| ENSG00000267787.1 |
Dasatinib |
Brain lower grade glioma |
0.040092279 |
Resistant |
| ENSG00000267858.1 |
Dasatinib |
Brain lower grade glioma |
0.016384202 |
Resistant |
| ENSG00000267871.1 |
Dasatinib |
Brain lower grade glioma |
0.015158821 |
Resistant |
| ENSG00000268205.1 |
Dasatinib |
Brain lower grade glioma |
0.025387831 |
Resistant |
| ENSG00000268262.1 |
Dasatinib |
Brain lower grade glioma |
0.02264365 |
Resistant |
| ENSG00000268307.1 |
Dasatinib |
Brain lower grade glioma |
0.010221581 |
Resistant |
| ENSG00000268375.1 |
Dasatinib |
Brain lower grade glioma |
0.044294551 |
Resistant |
| ENSG00000268471.3 |
Dasatinib |
Brain lower grade glioma |
0.020307232 |
Resistant |
| ENSG00000268573.1 |
Dasatinib |
Brain lower grade glioma |
0.000534759 |
Resistant |
| ENSG00000268584.1 |
Dasatinib |
Brain lower grade glioma |
0.003732935 |
Resistant |
| ENSG00000268605.1 |
Dasatinib |
Brain lower grade glioma |
0.034088578 |
Resistant |
| ENSG00000268670.1 |
Dasatinib |
Brain lower grade glioma |
0.034914949 |
Resistant |
| ENSG00000268683.1 |
Dasatinib |
Brain lower grade glioma |
0.038455565 |
Resistant |
| ENSG00000268836.1 |
Dasatinib |
Brain lower grade glioma |
0.026308574 |
Resistant |
| ENSG00000268912.1 |
Dasatinib |
Brain lower grade glioma |
0.01105972 |
Resistant |
| ENSG00000269038.1 |
Dasatinib |
Brain lower grade glioma |
0.011603339 |
Resistant |
| ENSG00000269054.1 |
Dasatinib |
Brain lower grade glioma |
0.012401302 |
Resistant |
| ENSG00000269082.1 |
Dasatinib |
Brain lower grade glioma |
0.02844269 |
Resistant |
| ENSG00000269086.2 |
Dasatinib |
Brain lower grade glioma |
0.0041803 |
Resistant |
| ENSG00000269191.1 |
Dasatinib |
Brain lower grade glioma |
0.003262474 |
Resistant |
| ENSG00000269194.1 |
Dasatinib |
Brain lower grade glioma |
0.048019463 |
Resistant |
| ENSG00000269386.1 |
Dasatinib |
Brain lower grade glioma |
0.000695538 |
Resistant |
| ENSG00000269425.1 |
Dasatinib |
Brain lower grade glioma |
0.022829884 |
Resistant |
| ENSG00000269473.1 |
Dasatinib |
Brain lower grade glioma |
0.00219656 |
Resistant |
| ENSG00000269489.1 |
Dasatinib |
Brain lower grade glioma |
0.006614642 |
Resistant |
| ENSG00000269609.1 |
Dasatinib |
Brain lower grade glioma |
0.001056764 |
Resistant |
| ENSG00000269694.1 |
Dasatinib |
Brain lower grade glioma |
0.00134915 |
Resistant |
| ENSG00000269792.1 |
Dasatinib |
Brain lower grade glioma |
0.019752278 |
Resistant |
| ENSG00000269814.1 |
Dasatinib |
Brain lower grade glioma |
0.022038794 |
Resistant |
| ENSG00000269815.1 |
Dasatinib |
Brain lower grade glioma |
0.038287142 |
Resistant |
| ENSG00000269896.1 |
Dasatinib |
Brain lower grade glioma |
0.019302302 |
Resistant |
| ENSG00000269911.1 |
Dasatinib |
Brain lower grade glioma |
0.024034387 |
Resistant |
| ENSG00000269921.1 |
Dasatinib |
Brain lower grade glioma |
0.003986607 |
Resistant |
| ENSG00000269938.1 |
Dasatinib |
Brain lower grade glioma |
0.005219991 |
Resistant |
| ENSG00000269947.1 |
Dasatinib |
Brain lower grade glioma |
0.040280072 |
Resistant |
| ENSG00000269951.1 |
Dasatinib |
Brain lower grade glioma |
0.001431586 |
Resistant |
| ENSG00000269972.1 |
Dasatinib |
Brain lower grade glioma |
0.004134609 |
Resistant |
| ENSG00000269978.1 |
Dasatinib |
Brain lower grade glioma |
0.010508395 |
Resistant |
| ENSG00000269987.1 |
Dasatinib |
Brain lower grade glioma |
0.003179904 |
Resistant |
| ENSG00000269997.1 |
Dasatinib |
Brain lower grade glioma |
0.029809546 |
Resistant |
| ENSG00000270010.1 |
Dasatinib |
Brain lower grade glioma |
0.011690298 |
Resistant |
| ENSG00000270012.1 |
Dasatinib |
Brain lower grade glioma |
0.001754169 |
Resistant |
| ENSG00000270018.1 |
Dasatinib |
Brain lower grade glioma |
0.004102481 |
Resistant |
| ENSG00000270019.1 |
Dasatinib |
Brain lower grade glioma |
0.001397 |
Resistant |
| ENSG00000270035.1 |
Dasatinib |
Brain lower grade glioma |
0.047269878 |
Resistant |
| ENSG00000270041.1 |
Dasatinib |
Brain lower grade glioma |
0.012110329 |
Resistant |
| ENSG00000270048.1 |
Dasatinib |
Brain lower grade glioma |
0.025504427 |
Resistant |
| ENSG00000270061.1 |
Dasatinib |
Brain lower grade glioma |
0.00152526 |
Resistant |
| ENSG00000270066.2 |
Dasatinib |
Brain lower grade glioma |
0.0000696 |
Resistant |
| ENSG00000270081.1 |
Dasatinib |
Brain lower grade glioma |
0.004020466 |
Resistant |
| ENSG00000270083.1 |
Dasatinib |
Brain lower grade glioma |
0.005029764 |
Resistant |
| ENSG00000270084.1 |
Dasatinib |
Brain lower grade glioma |
0.002902065 |
Resistant |
| ENSG00000270091.1 |
Dasatinib |
Brain lower grade glioma |
0.002898962 |
Resistant |
| ENSG00000270095.1 |
Dasatinib |
Brain lower grade glioma |
0.004950982 |
Resistant |
| ENSG00000270102.1 |
Dasatinib |
Brain lower grade glioma |
0.000654048 |
Resistant |
| ENSG00000270109.1 |
Dasatinib |
Brain lower grade glioma |
0.016274762 |
Resistant |
| ENSG00000270130.1 |
Dasatinib |
Brain lower grade glioma |
0.02765898 |
Resistant |
| ENSG00000270171.1 |
Dasatinib |
Brain lower grade glioma |
0.009671317 |
Resistant |
| ENSG00000270189.1 |
Dasatinib |
Brain lower grade glioma |
0.003178229 |
Resistant |
| ENSG00000270223.1 |
Dasatinib |
Brain lower grade glioma |
0.03779641 |
Resistant |
| ENSG00000270246.2 |
Dasatinib |
Brain lower grade glioma |
0.041356212 |
Resistant |
| ENSG00000270344.1 |
Dasatinib |
Brain lower grade glioma |
0.041578843 |
Resistant |
| ENSG00000270462.1 |
Dasatinib |
Brain lower grade glioma |
0.005053859 |
Resistant |
| ENSG00000270487.1 |
Dasatinib |
Brain lower grade glioma |
0.044543683 |
Resistant |
| ENSG00000270589.1 |
Dasatinib |
Brain lower grade glioma |
0.027726584 |
Resistant |
| ENSG00000270605.1 |
Dasatinib |
Brain lower grade glioma |
0.001837666 |
Resistant |
| ENSG00000270681.1 |
Dasatinib |
Brain lower grade glioma |
0.013430782 |
Resistant |
| ENSG00000270704.2 |
Dasatinib |
Brain lower grade glioma |
0.009397163 |
Resistant |
| ENSG00000270828.1 |
Dasatinib |
Brain lower grade glioma |
0.040436214 |
Resistant |
| ENSG00000270964.1 |
Dasatinib |
Brain lower grade glioma |
0.027822115 |
Resistant |
| ENSG00000271109.1 |
Dasatinib |
Brain lower grade glioma |
0.028202313 |
Resistant |
| ENSG00000271147.3 |
Dasatinib |
Brain lower grade glioma |
0.036858908 |
Resistant |
| ENSG00000271151.1 |
Dasatinib |
Brain lower grade glioma |
0.00384447 |
Resistant |
| ENSG00000271265.1 |
Dasatinib |
Brain lower grade glioma |
0.020231968 |
Resistant |
| ENSG00000271270.1 |
Dasatinib |
Brain lower grade glioma |
0.007559849 |
Resistant |
| ENSG00000271335.1 |
Dasatinib |
Brain lower grade glioma |
0.00276737 |
Resistant |
| ENSG00000271347.1 |
Dasatinib |
Brain lower grade glioma |
0.001140351 |
Resistant |
| ENSG00000271387.1 |
Dasatinib |
Brain lower grade glioma |
0.045318099 |
Resistant |
| ENSG00000271398.1 |
Dasatinib |
Brain lower grade glioma |
0.026224029 |
Resistant |
| ENSG00000271551.1 |
Dasatinib |
Brain lower grade glioma |
0.014408149 |
Resistant |
| ENSG00000271579.1 |
Dasatinib |
Brain lower grade glioma |
0.040812906 |
Resistant |
| ENSG00000271659.1 |
Dasatinib |
Brain lower grade glioma |
0.001455312 |
Resistant |
| ENSG00000271738.1 |
Dasatinib |
Brain lower grade glioma |
0.039177933 |
Resistant |
| ENSG00000271757.1 |
Dasatinib |
Brain lower grade glioma |
0.007779709 |
Resistant |
| ENSG00000271789.1 |
Dasatinib |
Brain lower grade glioma |
0.001327391 |
Resistant |
| ENSG00000271889.1 |
Dasatinib |
Brain lower grade glioma |
0.017786791 |
Resistant |
| ENSG00000271927.1 |
Dasatinib |
Brain lower grade glioma |
0.03093065 |
Resistant |
| ENSG00000271963.1 |
Dasatinib |
Brain lower grade glioma |
0.008264252 |
Resistant |
| ENSG00000271964.1 |
Dasatinib |
Brain lower grade glioma |
0.00115583 |
Resistant |
| ENSG00000271966.1 |
Dasatinib |
Brain lower grade glioma |
0.039902518 |
Resistant |
| ENSG00000271971.1 |
Dasatinib |
Brain lower grade glioma |
0.00341609 |
Resistant |
| ENSG00000271993.1 |
Dasatinib |
Brain lower grade glioma |
0.045561539 |
Resistant |
| ENSG00000271996.1 |
Dasatinib |
Brain lower grade glioma |
0.042084916 |
Resistant |
| ENSG00000271997.1 |
Dasatinib |
Brain lower grade glioma |
0.017911712 |
Resistant |
| ENSG00000271998.1 |
Dasatinib |
Brain lower grade glioma |
0.022258991 |
Resistant |
| ENSG00000272048.1 |
Dasatinib |
Brain lower grade glioma |
0.010079172 |
Resistant |
| ENSG00000272077.1 |
Dasatinib |
Brain lower grade glioma |
0.027027469 |
Resistant |
| ENSG00000272087.1 |
Dasatinib |
Brain lower grade glioma |
0.010452214 |
Resistant |
| ENSG00000272093.1 |
Dasatinib |
Brain lower grade glioma |
0.008594166 |
Resistant |
| ENSG00000272137.1 |
Dasatinib |
Brain lower grade glioma |
0.009142501 |
Resistant |
| ENSG00000272143.1 |
Dasatinib |
Brain lower grade glioma |
0.045948203 |
Resistant |
| ENSG00000272192.1 |
Dasatinib |
Brain lower grade glioma |
0.012403556 |
Resistant |
| ENSG00000272205.1 |
Dasatinib |
Brain lower grade glioma |
0.04092852 |
Resistant |
| ENSG00000272216.1 |
Dasatinib |
Brain lower grade glioma |
0.0380962 |
Resistant |
| ENSG00000272225.1 |
Dasatinib |
Brain lower grade glioma |
0.032742814 |
Resistant |
| ENSG00000272240.1 |
Dasatinib |
Brain lower grade glioma |
0.012104221 |
Resistant |
| ENSG00000272248.1 |
Dasatinib |
Brain lower grade glioma |
0.01649477 |
Resistant |
| ENSG00000272263.1 |
Dasatinib |
Brain lower grade glioma |
0.005219398 |
Resistant |
| ENSG00000272301.1 |
Dasatinib |
Brain lower grade glioma |
0.004705046 |
Resistant |
| ENSG00000272308.1 |
Dasatinib |
Brain lower grade glioma |
0.00000341 |
Resistant |
| ENSG00000272316.1 |
Dasatinib |
Brain lower grade glioma |
0.024783535 |
Resistant |
| ENSG00000272335.1 |
Dasatinib |
Brain lower grade glioma |
0.016223335 |
Resistant |
| ENSG00000272365.1 |
Dasatinib |
Brain lower grade glioma |
0.000776841 |
Resistant |
| ENSG00000272373.1 |
Dasatinib |
Brain lower grade glioma |
0.0000868 |
Resistant |
| ENSG00000272375.1 |
Dasatinib |
Brain lower grade glioma |
0.038785732 |
Resistant |
| ENSG00000272417.1 |
Dasatinib |
Brain lower grade glioma |
0.021467572 |
Resistant |
| ENSG00000272440.1 |
Dasatinib |
Brain lower grade glioma |
0.015734623 |
Resistant |
| ENSG00000272452.1 |
Dasatinib |
Brain lower grade glioma |
0.005271288 |
Resistant |
| ENSG00000272562.1 |
Dasatinib |
Brain lower grade glioma |
0.012351745 |
Resistant |
| ENSG00000272644.1 |
Dasatinib |
Brain lower grade glioma |
0.008347081 |
Resistant |
| ENSG00000272645.1 |
Dasatinib |
Brain lower grade glioma |
0.013958441 |
Resistant |
| ENSG00000272662.1 |
Dasatinib |
Brain lower grade glioma |
0.026403173 |
Resistant |
| ENSG00000272667.1 |
Dasatinib |
Brain lower grade glioma |
0.016429479 |
Resistant |
| ENSG00000272720.1 |
Dasatinib |
Brain lower grade glioma |
0.026208031 |
Resistant |
| ENSG00000272721.1 |
Dasatinib |
Brain lower grade glioma |
0.0442106 |
Resistant |
| ENSG00000272777.1 |
Dasatinib |
Brain lower grade glioma |
0.002568648 |
Resistant |
| ENSG00000272791.1 |
Dasatinib |
Brain lower grade glioma |
0.004769254 |
Resistant |
| ENSG00000272792.1 |
Dasatinib |
Brain lower grade glioma |
0.020191973 |
Resistant |
| ENSG00000272798.1 |
Dasatinib |
Brain lower grade glioma |
0.005257944 |
Resistant |
| ENSG00000272800.1 |
Dasatinib |
Brain lower grade glioma |
0.032771171 |
Resistant |
| ENSG00000272812.1 |
Dasatinib |
Brain lower grade glioma |
0.004884986 |
Resistant |
| ENSG00000272828.1 |
Dasatinib |
Brain lower grade glioma |
0.014610056 |
Resistant |
| ENSG00000272846.1 |
Dasatinib |
Brain lower grade glioma |
0.036208975 |
Resistant |
| ENSG00000272849.1 |
Dasatinib |
Brain lower grade glioma |
0.020086213 |
Resistant |
| ENSG00000272858.1 |
Dasatinib |
Brain lower grade glioma |
0.033598002 |
Resistant |
| ENSG00000272872.1 |
Dasatinib |
Brain lower grade glioma |
0.029211053 |
Resistant |
| ENSG00000272902.1 |
Dasatinib |
Brain lower grade glioma |
0.00013529 |
Resistant |
| ENSG00000272927.1 |
Dasatinib |
Brain lower grade glioma |
0.034896058 |
Resistant |
| ENSG00000272940.1 |
Dasatinib |
Brain lower grade glioma |
0.039901584 |
Resistant |
| ENSG00000272942.1 |
Dasatinib |
Brain lower grade glioma |
0.006523661 |
Resistant |
| ENSG00000272954.1 |
Dasatinib |
Brain lower grade glioma |
0.02240692 |
Resistant |
| ENSG00000272977.1 |
Dasatinib |
Brain lower grade glioma |
0.010166165 |
Resistant |
| ENSG00000272983.1 |
Dasatinib |
Brain lower grade glioma |
0.029464626 |
Resistant |
| ENSG00000272989.1 |
Dasatinib |
Brain lower grade glioma |
0.016657047 |
Resistant |
| ENSG00000272995.1 |
Dasatinib |
Brain lower grade glioma |
0.003636561 |
Resistant |
| ENSG00000273000.1 |
Dasatinib |
Brain lower grade glioma |
0.043896058 |
Resistant |
| ENSG00000273008.1 |
Dasatinib |
Brain lower grade glioma |
0.036195731 |
Resistant |
| ENSG00000273011.1 |
Dasatinib |
Brain lower grade glioma |
0.034192467 |
Resistant |
| ENSG00000273015.1 |
Dasatinib |
Brain lower grade glioma |
0.005396298 |
Resistant |
| ENSG00000273017.1 |
Dasatinib |
Brain lower grade glioma |
0.007136614 |
Resistant |
| ENSG00000273019.1 |
Dasatinib |
Brain lower grade glioma |
0.003964403 |
Resistant |
| ENSG00000273026.1 |
Dasatinib |
Brain lower grade glioma |
0.048768648 |
Resistant |
| ENSG00000273061.1 |
Dasatinib |
Brain lower grade glioma |
0.019998321 |
Resistant |
| ENSG00000273066.1 |
Dasatinib |
Brain lower grade glioma |
0.015513583 |
Resistant |
| ENSG00000273075.1 |
Dasatinib |
Brain lower grade glioma |
0.007110156 |
Resistant |
| ENSG00000273091.1 |
Dasatinib |
Brain lower grade glioma |
0.018157181 |
Resistant |
| ENSG00000273108.1 |
Dasatinib |
Brain lower grade glioma |
0.038331498 |
Resistant |
| ENSG00000273148.1 |
Dasatinib |
Brain lower grade glioma |
0.004634336 |
Resistant |
| ENSG00000273156.1 |
Dasatinib |
Brain lower grade glioma |
0.005477187 |
Resistant |
| ENSG00000273181.1 |
Dasatinib |
Brain lower grade glioma |
0.04172521 |
Resistant |
| ENSG00000273188.1 |
Dasatinib |
Brain lower grade glioma |
0.032385824 |
Resistant |
| ENSG00000273247.1 |
Dasatinib |
Brain lower grade glioma |
0.001417416 |
Resistant |
| ENSG00000273265.1 |
Dasatinib |
Brain lower grade glioma |
0.011914994 |
Resistant |
| ENSG00000273271.1 |
Dasatinib |
Brain lower grade glioma |
0.002832941 |
Resistant |
| ENSG00000273290.1 |
Dasatinib |
Brain lower grade glioma |
0.008922195 |
Resistant |
| ENSG00000273293.1 |
Dasatinib |
Brain lower grade glioma |
0.032222622 |
Resistant |
| ENSG00000273297.1 |
Dasatinib |
Brain lower grade glioma |
0.044531758 |
Resistant |
| ENSG00000273306.1 |
Dasatinib |
Brain lower grade glioma |
0.00105861 |
Resistant |
| ENSG00000273308.1 |
Dasatinib |
Brain lower grade glioma |
0.017677579 |
Resistant |
| ENSG00000273321.1 |
Dasatinib |
Brain lower grade glioma |
0.005812279 |
Resistant |
| ENSG00000273369.1 |
Dasatinib |
Brain lower grade glioma |
0.01366084 |
Resistant |
| ENSG00000273373.1 |
Dasatinib |
Brain lower grade glioma |
0.007599661 |
Resistant |
| ENSG00000273374.1 |
Dasatinib |
Brain lower grade glioma |
0.028945735 |
Resistant |
| ENSG00000273402.1 |
Dasatinib |
Brain lower grade glioma |
0.036665267 |
Resistant |
| ENSG00000273416.1 |
Dasatinib |
Brain lower grade glioma |
0.041593687 |
Resistant |
| ENSG00000273424.1 |
Dasatinib |
Brain lower grade glioma |
0.01143775 |
Resistant |
| ENSG00000273437.1 |
Dasatinib |
Brain lower grade glioma |
0.002347836 |
Resistant |
| ENSG00000273449.1 |
Dasatinib |
Brain lower grade glioma |
0.025596248 |
Resistant |
| ENSG00000273472.1 |
Dasatinib |
Brain lower grade glioma |
0.002857511 |
Resistant |
| ENSG00000273473.1 |
Dasatinib |
Brain lower grade glioma |
0.007460512 |
Resistant |
| ENSG00000273486.1 |
Dasatinib |
Brain lower grade glioma |
0.004488136 |
Resistant |
| ENSG00000132204.9 |
Dasatinib |
Lung squamous cell carcinoma |
0.0037772 |
Resistant |
| ENSG00000167912.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.03641608 |
Resistant |
| ENSG00000178412.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.016231086 |
Resistant |
| ENSG00000187621.10 |
Dasatinib |
Lung squamous cell carcinoma |
0.044591154 |
Resistant |
| ENSG00000196559.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.039928304 |
Resistant |
| ENSG00000197332.7 |
Dasatinib |
Lung squamous cell carcinoma |
0.015155909 |
Resistant |
| ENSG00000203362.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.010916219 |
Resistant |
| ENSG00000204934.6 |
Dasatinib |
Lung squamous cell carcinoma |
0.010078995 |
Resistant |
| ENSG00000205266.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.037398128 |
Resistant |
| ENSG00000215159.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.040982162 |
Resistant |
| ENSG00000223764.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.029043025 |
Resistant |
| ENSG00000223911.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044408776 |
Resistant |
| ENSG00000224342.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.028827887 |
Resistant |
| ENSG00000225235.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.014644469 |
Resistant |
| ENSG00000226920.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.04659047 |
Resistant |
| ENSG00000227161.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.04268427 |
Resistant |
| ENSG00000227484.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.04371633 |
Resistant |
| ENSG00000227617.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.010694099 |
Resistant |
| ENSG00000227906.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.038601003 |
Resistant |
| ENSG00000228016.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042929089 |
Resistant |
| ENSG00000228079.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033244165 |
Resistant |
| ENSG00000228141.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.014144253 |
Resistant |
| ENSG00000228271.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022336956 |
Resistant |
| ENSG00000228372.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.01229993 |
Resistant |
| ENSG00000228544.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.025774733 |
Resistant |
| ENSG00000228677.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044136587 |
Resistant |
| ENSG00000229582.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.000566246 |
Resistant |
| ENSG00000229852.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.00008 |
Resistant |
| ENSG00000230212.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.009111398 |
Resistant |
| ENSG00000230530.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.017809585 |
Resistant |
| ENSG00000230633.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.010972405 |
Resistant |
| ENSG00000231010.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.018412458 |
Resistant |
| ENSG00000231651.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.018460232 |
Resistant |
| ENSG00000231711.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.016164974 |
Resistant |
| ENSG00000231840.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.025354634 |
Resistant |
| ENSG00000231889.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.041036347 |
Resistant |
| ENSG00000231993.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.029217803 |
Resistant |
| ENSG00000232363.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.000021 |
Resistant |
| ENSG00000232593.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.006186975 |
Resistant |
| ENSG00000232710.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.005641736 |
Resistant |
| ENSG00000233038.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030750985 |
Resistant |
| ENSG00000233061.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.038200472 |
Resistant |
| ENSG00000233223.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.045705599 |
Resistant |
| ENSG00000233244.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.036683968 |
Resistant |
| ENSG00000234019.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.014354612 |
Resistant |
| ENSG00000234084.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.01945621 |
Resistant |
| ENSG00000234503.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.019495344 |
Resistant |
| ENSG00000234535.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.023726956 |
Resistant |
| ENSG00000234917.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02128547 |
Resistant |
| ENSG00000235423.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.031521475 |
Resistant |
| ENSG00000235461.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.000149532 |
Resistant |
| ENSG00000235560.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.0143274 |
Resistant |
| ENSG00000235740.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.034676781 |
Resistant |
| ENSG00000236556.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.020707604 |
Resistant |
| ENSG00000236901.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.036626662 |
Resistant |
| ENSG00000237037.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.002002986 |
Resistant |
| ENSG00000237481.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001076877 |
Resistant |
| ENSG00000237989.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.009039368 |
Resistant |
| ENSG00000239480.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.002566701 |
Resistant |
| ENSG00000240449.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.004261055 |
Resistant |
| ENSG00000241054.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.00094618 |
Resistant |
| ENSG00000241886.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.029530782 |
Resistant |
| ENSG00000243810.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.025852206 |
Resistant |
| ENSG00000246095.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.019366818 |
Resistant |
| ENSG00000246465.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.018684592 |
Resistant |
| ENSG00000246851.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042462394 |
Resistant |
| ENSG00000248559.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.002054871 |
Resistant |
| ENSG00000248774.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030057642 |
Resistant |
| ENSG00000250699.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.016067446 |
Resistant |
| ENSG00000250999.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.048800795 |
Resistant |
| ENSG00000251161.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.014175964 |
Resistant |
| ENSG00000251175.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030927602 |
Resistant |
| ENSG00000251221.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.039293412 |
Resistant |
| ENSG00000251379.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.048966089 |
Resistant |
| ENSG00000251666.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.008963389 |
Resistant |
| ENSG00000253194.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.003302889 |
Resistant |
| ENSG00000253567.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.029423424 |
Resistant |
| ENSG00000253773.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.017871751 |
Resistant |
| ENSG00000253844.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042449098 |
Resistant |
| ENSG00000254162.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.000739893 |
Resistant |
| ENSG00000254510.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021613809 |
Resistant |
| ENSG00000254691.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.00025578 |
Resistant |
| ENSG00000254777.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044500243 |
Resistant |
| ENSG00000254802.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021287753 |
Resistant |
| ENSG00000254814.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.028285271 |
Resistant |
| ENSG00000254898.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.002830933 |
Resistant |
| ENSG00000254900.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033432406 |
Resistant |
| ENSG00000255886.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.016860995 |
Resistant |
| ENSG00000256116.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.024582385 |
Resistant |
| ENSG00000256250.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.004216169 |
Resistant |
| ENSG00000256360.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021950603 |
Resistant |
| ENSG00000256984.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.0000279 |
Resistant |
| ENSG00000258603.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001806662 |
Resistant |
| ENSG00000258748.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.000482699 |
Resistant |
| ENSG00000259006.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.049782271 |
Resistant |
| ENSG00000259377.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.018243032 |
Resistant |
| ENSG00000259462.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.006871975 |
Resistant |
| ENSG00000259798.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022021492 |
Resistant |
| ENSG00000260060.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02928788 |
Resistant |
| ENSG00000260196.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.013981296 |
Resistant |
| ENSG00000260219.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.017821998 |
Resistant |
| ENSG00000260296.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.03846013 |
Resistant |
| ENSG00000260398.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.040834422 |
Resistant |
| ENSG00000260400.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.041844624 |
Resistant |
| ENSG00000260597.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.035640002 |
Resistant |
| ENSG00000260655.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02010601 |
Resistant |
| ENSG00000260830.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.011993361 |
Resistant |
| ENSG00000260838.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.029098388 |
Resistant |
| ENSG00000261098.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022826539 |
Resistant |
| ENSG00000261449.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.027921698 |
Resistant |
| ENSG00000261670.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042062782 |
Resistant |
| ENSG00000263167.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021314127 |
Resistant |
| ENSG00000263350.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.000180682 |
Resistant |
| ENSG00000263499.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.03898393 |
Resistant |
| ENSG00000263938.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022580249 |
Resistant |
| ENSG00000265130.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.0000913 |
Resistant |
| ENSG00000266601.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.045076362 |
Resistant |
| ENSG00000266969.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.029068644 |
Resistant |
| ENSG00000267018.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.0000349 |
Resistant |
| ENSG00000267183.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.011355142 |
Resistant |
| ENSG00000267211.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.014037987 |
Resistant |
| ENSG00000267249.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.000354628 |
Resistant |
| ENSG00000267347.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.038970888 |
Resistant |
| ENSG00000267778.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.047163939 |
Resistant |
| ENSG00000267868.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001642286 |
Resistant |
| ENSG00000268047.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.035580118 |
Resistant |
| ENSG00000268093.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.002088664 |
Resistant |
| ENSG00000268289.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.034261337 |
Resistant |
| ENSG00000268307.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.003869566 |
Resistant |
| ENSG00000268543.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.04053427 |
Resistant |
| ENSG00000268583.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.047979992 |
Resistant |
| ENSG00000268670.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.025935688 |
Resistant |
| ENSG00000269091.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.016753715 |
Resistant |
| ENSG00000269194.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.024533474 |
Resistant |
| ENSG00000269356.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042794886 |
Resistant |
| ENSG00000269376.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044972117 |
Resistant |
| ENSG00000269473.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.048202941 |
Resistant |
| ENSG00000269489.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.032666604 |
Resistant |
| ENSG00000269560.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.010980407 |
Resistant |
| ENSG00000269978.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044735323 |
Resistant |
| ENSG00000270012.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02750586 |
Resistant |
| ENSG00000270068.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.008859769 |
Resistant |
| ENSG00000270083.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.034176087 |
Resistant |
| ENSG00000270104.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001987745 |
Resistant |
| ENSG00000270189.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.005836271 |
Resistant |
| ENSG00000271185.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.038645064 |
Resistant |
| ENSG00000271314.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.012601751 |
Resistant |
| ENSG00000271849.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.017466665 |
Resistant |
| ENSG00000271927.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.00290198 |
Resistant |
| ENSG00000271948.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.016384044 |
Resistant |
| ENSG00000271981.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.024617097 |
Resistant |
| ENSG00000272004.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.023851117 |
Resistant |
| ENSG00000272338.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.005064954 |
Resistant |
| ENSG00000272372.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.0000385 |
Resistant |
| ENSG00000272472.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.038432298 |
Resistant |
| ENSG00000272524.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030345063 |
Resistant |
| ENSG00000272699.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.005027462 |
Resistant |
| ENSG00000272707.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.008129903 |
Resistant |
| ENSG00000272717.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02477721 |
Resistant |
| ENSG00000272954.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.029330404 |
Resistant |
| ENSG00000273056.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.010914678 |
Resistant |
| ENSG00000273066.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02138647 |
Resistant |
| ENSG00000273237.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.028149247 |
Resistant |
| ENSG00000273295.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.005164041 |
Resistant |
| ENSG00000273342.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.026291204 |
Resistant |
| ENSG00000273353.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.003506758 |
Resistant |
| ENSG00000273447.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044102066 |
Resistant |
| ENSG00000182873.4 |
Dasatinib |
Skin cutaneous melanoma |
0.036414535 |
Resistant |
| ENSG00000224621.1 |
Dasatinib |
Skin cutaneous melanoma |
0.034200083 |
Resistant |
| ENSG00000226648.1 |
Dasatinib |
Skin cutaneous melanoma |
0.006026322 |
Resistant |
| ENSG00000227110.2 |
Dasatinib |
Skin cutaneous melanoma |
0.027339459 |
Resistant |
| ENSG00000227372.6 |
Dasatinib |
Skin cutaneous melanoma |
0.04410139 |
Resistant |
| ENSG00000228124.1 |
Dasatinib |
Skin cutaneous melanoma |
0.032722912 |
Resistant |
| ENSG00000228204.2 |
Dasatinib |
Skin cutaneous melanoma |
0.024519935 |
Resistant |
| ENSG00000231856.1 |
Dasatinib |
Skin cutaneous melanoma |
0.021797806 |
Resistant |
| ENSG00000233864.3 |
Dasatinib |
Skin cutaneous melanoma |
0.026148247 |
Resistant |
| ENSG00000236842.1 |
Dasatinib |
Skin cutaneous melanoma |
0.041021264 |
Resistant |
| ENSG00000237436.1 |
Dasatinib |
Skin cutaneous melanoma |
0.018282237 |
Resistant |
| ENSG00000238005.2 |
Dasatinib |
Skin cutaneous melanoma |
0.042002536 |
Resistant |
| ENSG00000239593.1 |
Dasatinib |
Skin cutaneous melanoma |
0.019167379 |
Resistant |
| ENSG00000245729.1 |
Dasatinib |
Skin cutaneous melanoma |
0.014039156 |
Resistant |
| ENSG00000246859.2 |
Dasatinib |
Skin cutaneous melanoma |
0.016789253 |
Resistant |
| ENSG00000251221.1 |
Dasatinib |
Skin cutaneous melanoma |
0.013031814 |
Resistant |
| ENSG00000254855.1 |
Dasatinib |
Skin cutaneous melanoma |
0.015821668 |
Resistant |
| ENSG00000255139.1 |
Dasatinib |
Skin cutaneous melanoma |
0.047980704 |
Resistant |
| ENSG00000255337.1 |
Dasatinib |
Skin cutaneous melanoma |
0.041559883 |
Resistant |
| ENSG00000259081.1 |
Dasatinib |
Skin cutaneous melanoma |
0.01476488 |
Resistant |
| ENSG00000259767.1 |
Dasatinib |
Skin cutaneous melanoma |
0.014090353 |
Resistant |
| ENSG00000260536.1 |
Dasatinib |
Skin cutaneous melanoma |
0.020832064 |
Resistant |
| ENSG00000260891.1 |
Dasatinib |
Skin cutaneous melanoma |
0.018063534 |
Resistant |
| ENSG00000261005.1 |
Dasatinib |
Skin cutaneous melanoma |
0.001304736 |
Resistant |
| ENSG00000261105.1 |
Dasatinib |
Skin cutaneous melanoma |
0.039837811 |
Resistant |
| ENSG00000261488.1 |
Dasatinib |
Skin cutaneous melanoma |
0.039908734 |
Resistant |
| ENSG00000262152.2 |
Dasatinib |
Skin cutaneous melanoma |
0.042736431 |
Resistant |
| ENSG00000267150.1 |
Dasatinib |
Skin cutaneous melanoma |
0.016312572 |
Resistant |
| ENSG00000267934.1 |
Dasatinib |
Skin cutaneous melanoma |
0.045479115 |
Resistant |
| ENSG00000269836.1 |
Dasatinib |
Skin cutaneous melanoma |
0.031040245 |
Resistant |
| ENSG00000269999.1 |
Dasatinib |
Skin cutaneous melanoma |
0.016885618 |
Resistant |
| ENSG00000270195.1 |
Dasatinib |
Skin cutaneous melanoma |
0.048142329 |
Resistant |
| ENSG00000271009.2 |
Dasatinib |
Skin cutaneous melanoma |
0.031850441 |
Resistant |
| ENSG00000271200.1 |
Dasatinib |
Skin cutaneous melanoma |
0.007589549 |
Resistant |
| ENSG00000272198.1 |
Dasatinib |
Skin cutaneous melanoma |
0.047456914 |
Resistant |
| ENSG00000272508.1 |
Dasatinib |
Skin cutaneous melanoma |
0.042741238 |
Resistant |
| ENSG00000272549.1 |
Dasatinib |
Skin cutaneous melanoma |
0.045696912 |
Resistant |
| ENSG00000272769.1 |
Dasatinib |
Skin cutaneous melanoma |
0.004205014 |
Resistant |
| ENSG00000272810.1 |
Dasatinib |
Skin cutaneous melanoma |
0.039623608 |
Resistant |
| ENSG00000177738.3 |
Dasatinib |
Breast invasive carcinoma |
0.027997119 |
Sensitive |
| ENSG00000177853.10 |
Dasatinib |
Breast invasive carcinoma |
0.025603936 |
Sensitive |
| ENSG00000180846.4 |
Dasatinib |
Breast invasive carcinoma |
0.009200172 |
Sensitive |
| ENSG00000206195.6 |
Dasatinib |
Breast invasive carcinoma |
0.013767502 |
Sensitive |
| ENSG00000223356.1 |
Dasatinib |
Breast invasive carcinoma |
0.040854251 |
Sensitive |
| ENSG00000223380.3 |
Dasatinib |
Breast invasive carcinoma |
0.001414818 |
Sensitive |
| ENSG00000223692.1 |
Dasatinib |
Breast invasive carcinoma |
0.014658455 |
Sensitive |
| ENSG00000223779.4 |
Dasatinib |
Breast invasive carcinoma |
0.027533373 |
Sensitive |
| ENSG00000223884.1 |
Dasatinib |
Breast invasive carcinoma |
0.022016114 |
Sensitive |
| ENSG00000224905.2 |
Dasatinib |
Breast invasive carcinoma |
0.005334016 |
Sensitive |
| ENSG00000224992.1 |
Dasatinib |
Breast invasive carcinoma |
0.016656994 |
Sensitive |
| ENSG00000225703.1 |
Dasatinib |
Breast invasive carcinoma |
0.018533576 |
Sensitive |
| ENSG00000225981.1 |
Dasatinib |
Breast invasive carcinoma |
0.001112314 |
Sensitive |
| ENSG00000226291.1 |
Dasatinib |
Breast invasive carcinoma |
0.00292823 |
Sensitive |
| ENSG00000228022.1 |
Dasatinib |
Breast invasive carcinoma |
0.046293721 |
Sensitive |
| ENSG00000228302.2 |
Dasatinib |
Breast invasive carcinoma |
0.015677115 |
Sensitive |
| ENSG00000228838.1 |
Dasatinib |
Breast invasive carcinoma |
0.034073903 |
Sensitive |
| ENSG00000229021.2 |
Dasatinib |
Breast invasive carcinoma |
0.019637298 |
Sensitive |
| ENSG00000229780.1 |
Dasatinib |
Breast invasive carcinoma |
0.02766239 |
Sensitive |
| ENSG00000230084.1 |
Dasatinib |
Breast invasive carcinoma |
0.019316952 |
Sensitive |
| ENSG00000230699.2 |
Dasatinib |
Breast invasive carcinoma |
0.029073729 |
Sensitive |
| ENSG00000231010.1 |
Dasatinib |
Breast invasive carcinoma |
0.03997065 |
Sensitive |
| ENSG00000231154.1 |
Dasatinib |
Breast invasive carcinoma |
0.042026525 |
Sensitive |
| ENSG00000231407.1 |
Dasatinib |
Breast invasive carcinoma |
0.036676289 |
Sensitive |
| ENSG00000231711.2 |
Dasatinib |
Breast invasive carcinoma |
0.03462233 |
Sensitive |
| ENSG00000232151.5 |
Dasatinib |
Breast invasive carcinoma |
0.017445392 |
Sensitive |
| ENSG00000232480.1 |
Dasatinib |
Breast invasive carcinoma |
0.027551931 |
Sensitive |
| ENSG00000232519.2 |
Dasatinib |
Breast invasive carcinoma |
0.001708398 |
Sensitive |
| ENSG00000232586.1 |
Dasatinib |
Breast invasive carcinoma |
0.046017663 |
Sensitive |
| ENSG00000233334.2 |
Dasatinib |
Breast invasive carcinoma |
0.018061263 |
Sensitive |
| ENSG00000233547.1 |
Dasatinib |
Breast invasive carcinoma |
0.042799965 |
Sensitive |
| ENSG00000233901.1 |
Dasatinib |
Breast invasive carcinoma |
0.049228905 |
Sensitive |
| ENSG00000234378.1 |
Dasatinib |
Breast invasive carcinoma |
0.013248057 |
Sensitive |
| ENSG00000234617.1 |
Dasatinib |
Breast invasive carcinoma |
0.029519423 |
Sensitive |
| ENSG00000235027.1 |
Dasatinib |
Breast invasive carcinoma |
0.008268163 |
Sensitive |
| ENSG00000235703.1 |
Dasatinib |
Breast invasive carcinoma |
0.015477094 |
Sensitive |
| ENSG00000235910.1 |
Dasatinib |
Breast invasive carcinoma |
0.006223226 |
Sensitive |
| ENSG00000235947.1 |
Dasatinib |
Breast invasive carcinoma |
0.012675822 |
Sensitive |
| ENSG00000236199.1 |
Dasatinib |
Breast invasive carcinoma |
0.008415009 |
Sensitive |
| ENSG00000236526.1 |
Dasatinib |
Breast invasive carcinoma |
0.046414451 |
Sensitive |
| ENSG00000236869.1 |
Dasatinib |
Breast invasive carcinoma |
0.04512846 |
Sensitive |
| ENSG00000236943.2 |
Dasatinib |
Breast invasive carcinoma |
0.042987983 |
Sensitive |
| ENSG00000237491.4 |
Dasatinib |
Breast invasive carcinoma |
0.009678451 |
Sensitive |
| ENSG00000237502.2 |
Dasatinib |
Breast invasive carcinoma |
0.016446739 |
Sensitive |
| ENSG00000237781.2 |
Dasatinib |
Breast invasive carcinoma |
0.006391425 |
Sensitive |
| ENSG00000237819.1 |
Dasatinib |
Breast invasive carcinoma |
0.006179099 |
Sensitive |
| ENSG00000237938.1 |
Dasatinib |
Breast invasive carcinoma |
0.026731791 |
Sensitive |
| ENSG00000237998.3 |
Dasatinib |
Breast invasive carcinoma |
0.035964402 |
Sensitive |
| ENSG00000238058.1 |
Dasatinib |
Breast invasive carcinoma |
0.049983072 |
Sensitive |
| ENSG00000238186.1 |
Dasatinib |
Breast invasive carcinoma |
0.027412416 |
Sensitive |
| ENSG00000238246.1 |
Dasatinib |
Breast invasive carcinoma |
0.026958736 |
Sensitive |
| ENSG00000241769.3 |
Dasatinib |
Breast invasive carcinoma |
0.018773984 |
Sensitive |
| ENSG00000242288.6 |
Dasatinib |
Breast invasive carcinoma |
0.043140143 |
Sensitive |
| ENSG00000242791.2 |
Dasatinib |
Breast invasive carcinoma |
0.001393293 |
Sensitive |
| ENSG00000243107.1 |
Dasatinib |
Breast invasive carcinoma |
0.006357084 |
Sensitive |
| ENSG00000244306.5 |
Dasatinib |
Breast invasive carcinoma |
0.036631406 |
Sensitive |
| ENSG00000245322.2 |
Dasatinib |
Breast invasive carcinoma |
0.046384662 |
Sensitive |
| ENSG00000246250.2 |
Dasatinib |
Breast invasive carcinoma |
0.028871076 |
Sensitive |
| ENSG00000246323.2 |
Dasatinib |
Breast invasive carcinoma |
0.006752556 |
Sensitive |
| ENSG00000248734.2 |
Dasatinib |
Breast invasive carcinoma |
0.029719791 |
Sensitive |
| ENSG00000248810.1 |
Dasatinib |
Breast invasive carcinoma |
0.012671287 |
Sensitive |
| ENSG00000250397.2 |
Dasatinib |
Breast invasive carcinoma |
0.010515307 |
Sensitive |
| ENSG00000250950.1 |
Dasatinib |
Breast invasive carcinoma |
0.043722537 |
Sensitive |
| ENSG00000251164.1 |
Dasatinib |
Breast invasive carcinoma |
0.012523187 |
Sensitive |
| ENSG00000254631.1 |
Dasatinib |
Breast invasive carcinoma |
0.046135734 |
Sensitive |
| ENSG00000254964.1 |
Dasatinib |
Breast invasive carcinoma |
0.014050069 |
Sensitive |
| ENSG00000255160.1 |
Dasatinib |
Breast invasive carcinoma |
0.029819454 |
Sensitive |
| ENSG00000255449.1 |
Dasatinib |
Breast invasive carcinoma |
0.038808612 |
Sensitive |
| ENSG00000256967.1 |
Dasatinib |
Breast invasive carcinoma |
0.047177216 |
Sensitive |
| ENSG00000257913.1 |
Dasatinib |
Breast invasive carcinoma |
0.034410746 |
Sensitive |
| ENSG00000258545.1 |
Dasatinib |
Breast invasive carcinoma |
0.035222555 |
Sensitive |
| ENSG00000258633.1 |
Dasatinib |
Breast invasive carcinoma |
0.037475347 |
Sensitive |
| ENSG00000259062.1 |
Dasatinib |
Breast invasive carcinoma |
0.044483095 |
Sensitive |
| ENSG00000260650.1 |
Dasatinib |
Breast invasive carcinoma |
0.032181319 |
Sensitive |
| ENSG00000260660.1 |
Dasatinib |
Breast invasive carcinoma |
0.048823145 |
Sensitive |
| ENSG00000261002.1 |
Dasatinib |
Breast invasive carcinoma |
0.037978731 |
Sensitive |
| ENSG00000262434.1 |
Dasatinib |
Breast invasive carcinoma |
0.04423122 |
Sensitive |
| ENSG00000264932.2 |
Dasatinib |
Breast invasive carcinoma |
0.016484978 |
Sensitive |
| ENSG00000266667.1 |
Dasatinib |
Breast invasive carcinoma |
0.00131404 |
Sensitive |
| ENSG00000266897.1 |
Dasatinib |
Breast invasive carcinoma |
0.019440648 |
Sensitive |
| ENSG00000267212.1 |
Dasatinib |
Breast invasive carcinoma |
0.025222446 |
Sensitive |
| ENSG00000268549.1 |
Dasatinib |
Breast invasive carcinoma |
0.019763418 |
Sensitive |
| ENSG00000268743.1 |
Dasatinib |
Breast invasive carcinoma |
0.00072385 |
Sensitive |
| ENSG00000268938.2 |
Dasatinib |
Breast invasive carcinoma |
0.019058029 |
Sensitive |
| ENSG00000269293.2 |
Dasatinib |
Breast invasive carcinoma |
0.014461475 |
Sensitive |
| ENSG00000269806.1 |
Dasatinib |
Breast invasive carcinoma |
0.035522444 |
Sensitive |
| ENSG00000269971.1 |
Dasatinib |
Breast invasive carcinoma |
0.009814994 |
Sensitive |
| ENSG00000270060.1 |
Dasatinib |
Breast invasive carcinoma |
0.032730256 |
Sensitive |
| ENSG00000270116.1 |
Dasatinib |
Breast invasive carcinoma |
0.015821099 |
Sensitive |
| ENSG00000272004.1 |
Dasatinib |
Breast invasive carcinoma |
0.049890939 |
Sensitive |
| ENSG00000272070.1 |
Dasatinib |
Breast invasive carcinoma |
0.027629003 |
Sensitive |
| ENSG00000272076.1 |
Dasatinib |
Breast invasive carcinoma |
0.040300808 |
Sensitive |
| ENSG00000272374.1 |
Dasatinib |
Breast invasive carcinoma |
0.017156635 |
Sensitive |
| ENSG00000272438.1 |
Dasatinib |
Breast invasive carcinoma |
0.016137346 |
Sensitive |
| ENSG00000272864.1 |
Dasatinib |
Breast invasive carcinoma |
0.008817176 |
Sensitive |
| ENSG00000273137.1 |
Dasatinib |
Breast invasive carcinoma |
0.032700129 |
Sensitive |
| ENSG00000170846.11 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028766365 |
Sensitive |
| ENSG00000175701.6 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016883323 |
Sensitive |
| ENSG00000182109.3 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008554097 |
Sensitive |
| ENSG00000224738.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027091431 |
Sensitive |
| ENSG00000225439.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037432822 |
Sensitive |
| ENSG00000226332.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025259887 |
Sensitive |
| ENSG00000227372.6 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017226395 |
Sensitive |
| ENSG00000227512.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040852308 |
Sensitive |
| ENSG00000228544.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024614465 |
Sensitive |
| ENSG00000228554.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031200194 |
Sensitive |
| ENSG00000228763.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018505514 |
Sensitive |
| ENSG00000228838.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014041043 |
Sensitive |
| ENSG00000230002.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013857273 |
Sensitive |
| ENSG00000231073.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041241766 |
Sensitive |
| ENSG00000231113.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024962857 |
Sensitive |
| ENSG00000231851.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017040342 |
Sensitive |
| ENSG00000232762.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03364888 |
Sensitive |
| ENSG00000233461.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035118754 |
Sensitive |
| ENSG00000233613.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.009077195 |
Sensitive |
| ENSG00000233757.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043378424 |
Sensitive |
| ENSG00000234185.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024322639 |
Sensitive |
| ENSG00000235837.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024272382 |
Sensitive |
| ENSG00000236269.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02327051 |
Sensitive |
| ENSG00000236308.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005433801 |
Sensitive |
| ENSG00000237015.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039908486 |
Sensitive |
| ENSG00000237836.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047018698 |
Sensitive |
| ENSG00000242125.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028468094 |
Sensitive |
| ENSG00000245526.4 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033177086 |
Sensitive |
| ENSG00000248223.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028877099 |
Sensitive |
| ENSG00000250802.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031244176 |
Sensitive |
| ENSG00000257605.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013524219 |
Sensitive |
| ENSG00000258136.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038919816 |
Sensitive |
| ENSG00000258525.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018191683 |
Sensitive |
| ENSG00000258658.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004434231 |
Sensitive |
| ENSG00000260269.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040504337 |
Sensitive |
| ENSG00000260591.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020619877 |
Sensitive |
| ENSG00000260766.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015187071 |
Sensitive |
| ENSG00000260891.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027167165 |
Sensitive |
| ENSG00000261267.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040867767 |
Sensitive |
| ENSG00000261560.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013848826 |
Sensitive |
| ENSG00000261712.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014942246 |
Sensitive |
| ENSG00000262848.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032096749 |
Sensitive |
| ENSG00000263470.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006332898 |
Sensitive |
| ENSG00000263975.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044564891 |
Sensitive |
| ENSG00000264608.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030054541 |
Sensitive |
| ENSG00000265206.2 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013173365 |
Sensitive |
| ENSG00000265800.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022981225 |
Sensitive |
| ENSG00000266895.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015383507 |
Sensitive |
| ENSG00000266969.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042045175 |
Sensitive |
| ENSG00000267886.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011627238 |
Sensitive |
| ENSG00000270062.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017412869 |
Sensitive |
| ENSG00000270346.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01313104 |
Sensitive |
| ENSG00000270361.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039526643 |
Sensitive |
| ENSG00000271359.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024215188 |
Sensitive |
| ENSG00000271554.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029079457 |
Sensitive |
| ENSG00000271778.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04984704 |
Sensitive |
| ENSG00000271815.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005521394 |
Sensitive |
| ENSG00000272077.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019095288 |
Sensitive |
| ENSG00000272112.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039177693 |
Sensitive |
| ENSG00000273076.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027826706 |
Sensitive |
| ENSG00000273309.1 |
Dasatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030853949 |
Sensitive |
| ENSG00000189223.9 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.030392543 |
Sensitive |
| ENSG00000226419.2 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.038286645 |
Sensitive |
| ENSG00000228629.2 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.048931823 |
Sensitive |
| ENSG00000234263.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.04591379 |
Sensitive |
| ENSG00000235843.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.03091086 |
Sensitive |
| ENSG00000236537.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.024036647 |
Sensitive |
| ENSG00000237200.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.037811817 |
Sensitive |
| ENSG00000237998.3 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.049130888 |
Sensitive |
| ENSG00000243055.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.038404705 |
Sensitive |
| ENSG00000244998.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.006121555 |
Sensitive |
| ENSG00000246174.3 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.04552277 |
Sensitive |
| ENSG00000246263.2 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.019405344 |
Sensitive |
| ENSG00000250027.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.019384409 |
Sensitive |
| ENSG00000251136.4 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.012080303 |
Sensitive |
| ENSG00000253392.2 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.030722803 |
Sensitive |
| ENSG00000253754.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.045439853 |
Sensitive |
| ENSG00000255520.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.046539419 |
Sensitive |
| ENSG00000256712.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.003322644 |
Sensitive |
| ENSG00000257563.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.042185118 |
Sensitive |
| ENSG00000258302.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.003294093 |
Sensitive |
| ENSG00000258354.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.011438178 |
Sensitive |
| ENSG00000260942.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.012006976 |
Sensitive |
| ENSG00000260953.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.039434569 |
Sensitive |
| ENSG00000261207.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.044613458 |
Sensitive |
| ENSG00000262165.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.037171747 |
Sensitive |
| ENSG00000262873.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.019674237 |
Sensitive |
| ENSG00000264112.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.029704937 |
Sensitive |
| ENSG00000266709.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.042828281 |
Sensitive |
| ENSG00000267248.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.01897114 |
Sensitive |
| ENSG00000267265.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.023959522 |
Sensitive |
| ENSG00000267416.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.019720748 |
Sensitive |
| ENSG00000267449.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.010918354 |
Sensitive |
| ENSG00000267750.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.048905719 |
Sensitive |
| ENSG00000268573.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.047610922 |
Sensitive |
| ENSG00000269392.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.035910711 |
Sensitive |
| ENSG00000271382.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.028093012 |
Sensitive |
| ENSG00000271398.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.022349309 |
Sensitive |
| ENSG00000272240.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.026852467 |
Sensitive |
| ENSG00000272812.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.003278643 |
Sensitive |
| ENSG00000272815.1 |
Dasatinib |
Chronic Lymphocytic Leukemia |
0.033620834 |
Sensitive |
| ENSG00000172965.10 |
Dasatinib |
Brain lower grade glioma |
0.008903015 |
Sensitive |
| ENSG00000174171.4 |
Dasatinib |
Brain lower grade glioma |
0.008298464 |
Sensitive |
| ENSG00000177337.3 |
Dasatinib |
Brain lower grade glioma |
0.010550354 |
Sensitive |
| ENSG00000177738.3 |
Dasatinib |
Brain lower grade glioma |
0.023666916 |
Sensitive |
| ENSG00000177993.3 |
Dasatinib |
Brain lower grade glioma |
0.02089713 |
Sensitive |
| ENSG00000186594.8 |
Dasatinib |
Brain lower grade glioma |
0.000903075 |
Sensitive |
| ENSG00000187229.3 |
Dasatinib |
Brain lower grade glioma |
0.028443256 |
Sensitive |
| ENSG00000187621.10 |
Dasatinib |
Brain lower grade glioma |
0.04887527 |
Sensitive |
| ENSG00000189149.7 |
Dasatinib |
Brain lower grade glioma |
0.010389978 |
Sensitive |
| ENSG00000196972.6 |
Dasatinib |
Brain lower grade glioma |
0.008219032 |
Sensitive |
| ENSG00000203706.4 |
Dasatinib |
Brain lower grade glioma |
0.017876656 |
Sensitive |
| ENSG00000203721.1 |
Dasatinib |
Brain lower grade glioma |
0.049179315 |
Sensitive |
| ENSG00000205488.4 |
Dasatinib |
Brain lower grade glioma |
0.038778325 |
Sensitive |
| ENSG00000214407.3 |
Dasatinib |
Brain lower grade glioma |
0.047395281 |
Sensitive |
| ENSG00000214922.5 |
Dasatinib |
Brain lower grade glioma |
0.003359405 |
Sensitive |
| ENSG00000215068.3 |
Dasatinib |
Brain lower grade glioma |
0.025493029 |
Sensitive |
| ENSG00000215863.2 |
Dasatinib |
Brain lower grade glioma |
0.002332361 |
Sensitive |
| ENSG00000215869.3 |
Dasatinib |
Brain lower grade glioma |
0.049593477 |
Sensitive |
| ENSG00000222041.6 |
Dasatinib |
Brain lower grade glioma |
0.011003767 |
Sensitive |
| ENSG00000223382.3 |
Dasatinib |
Brain lower grade glioma |
0.047399782 |
Sensitive |
| ENSG00000223478.1 |
Dasatinib |
Brain lower grade glioma |
0.003932059 |
Sensitive |
| ENSG00000223749.3 |
Dasatinib |
Brain lower grade glioma |
0.013827721 |
Sensitive |
| ENSG00000223759.2 |
Dasatinib |
Brain lower grade glioma |
0.006240648 |
Sensitive |
| ENSG00000223804.1 |
Dasatinib |
Brain lower grade glioma |
0.001626745 |
Sensitive |
| ENSG00000223855.1 |
Dasatinib |
Brain lower grade glioma |
0.046602794 |
Sensitive |
| ENSG00000224116.2 |
Dasatinib |
Brain lower grade glioma |
0.024692893 |
Sensitive |
| ENSG00000224409.1 |
Dasatinib |
Brain lower grade glioma |
0.017617987 |
Sensitive |
| ENSG00000224468.3 |
Dasatinib |
Brain lower grade glioma |
0.035617095 |
Sensitive |
| ENSG00000224687.1 |
Dasatinib |
Brain lower grade glioma |
0.023682574 |
Sensitive |
| ENSG00000224821.5 |
Dasatinib |
Brain lower grade glioma |
0.028263634 |
Sensitive |
| ENSG00000224959.1 |
Dasatinib |
Brain lower grade glioma |
0.009782898 |
Sensitive |
| ENSG00000225177.1 |
Dasatinib |
Brain lower grade glioma |
0.013049371 |
Sensitive |
| ENSG00000225187.1 |
Dasatinib |
Brain lower grade glioma |
0.018763161 |
Sensitive |
| ENSG00000225762.1 |
Dasatinib |
Brain lower grade glioma |
0.020037301 |
Sensitive |
| ENSG00000225916.1 |
Dasatinib |
Brain lower grade glioma |
0.003927979 |
Sensitive |
| ENSG00000225963.3 |
Dasatinib |
Brain lower grade glioma |
0.045691887 |
Sensitive |
| ENSG00000226115.1 |
Dasatinib |
Brain lower grade glioma |
0.041721358 |
Sensitive |
| ENSG00000226237.1 |
Dasatinib |
Brain lower grade glioma |
0.035007174 |
Sensitive |
| ENSG00000226287.3 |
Dasatinib |
Brain lower grade glioma |
0.0000471 |
Sensitive |
| ENSG00000226380.3 |
Dasatinib |
Brain lower grade glioma |
0.017905564 |
Sensitive |
| ENSG00000226520.1 |
Dasatinib |
Brain lower grade glioma |
0.018791872 |
Sensitive |
| ENSG00000226637.1 |
Dasatinib |
Brain lower grade glioma |
0.004129615 |
Sensitive |
| ENSG00000227036.2 |
Dasatinib |
Brain lower grade glioma |
0.032962887 |
Sensitive |
| ENSG00000227053.1 |
Dasatinib |
Brain lower grade glioma |
0.018132874 |
Sensitive |
| ENSG00000227193.2 |
Dasatinib |
Brain lower grade glioma |
0.039262177 |
Sensitive |
| ENSG00000227279.1 |
Dasatinib |
Brain lower grade glioma |
0.026363468 |
Sensitive |
| ENSG00000227477.1 |
Dasatinib |
Brain lower grade glioma |
0.035261646 |
Sensitive |
| ENSG00000227496.1 |
Dasatinib |
Brain lower grade glioma |
0.040799547 |
Sensitive |
| ENSG00000227741.1 |
Dasatinib |
Brain lower grade glioma |
0.021346607 |
Sensitive |
| ENSG00000228172.1 |
Dasatinib |
Brain lower grade glioma |
0.014078223 |
Sensitive |
| ENSG00000228265.1 |
Dasatinib |
Brain lower grade glioma |
0.047442793 |
Sensitive |
| ENSG00000228630.1 |
Dasatinib |
Brain lower grade glioma |
0.049386575 |
Sensitive |
| ENSG00000228661.1 |
Dasatinib |
Brain lower grade glioma |
0.005398029 |
Sensitive |
| ENSG00000229118.1 |
Dasatinib |
Brain lower grade glioma |
0.02993405 |
Sensitive |
| ENSG00000229124.2 |
Dasatinib |
Brain lower grade glioma |
0.004436087 |
Sensitive |
| ENSG00000229373.4 |
Dasatinib |
Brain lower grade glioma |
0.020000927 |
Sensitive |
| ENSG00000229512.1 |
Dasatinib |
Brain lower grade glioma |
0.02666585 |
Sensitive |
| ENSG00000229656.2 |
Dasatinib |
Brain lower grade glioma |
0.00418162 |
Sensitive |
| ENSG00000229852.2 |
Dasatinib |
Brain lower grade glioma |
0.048423836 |
Sensitive |
| ENSG00000229874.2 |
Dasatinib |
Brain lower grade glioma |
0.000762544 |
Sensitive |
| ENSG00000230015.2 |
Dasatinib |
Brain lower grade glioma |
0.007536087 |
Sensitive |
| ENSG00000230337.1 |
Dasatinib |
Brain lower grade glioma |
0.011346653 |
Sensitive |
| ENSG00000230438.5 |
Dasatinib |
Brain lower grade glioma |
0.036191261 |
Sensitive |
| ENSG00000230499.1 |
Dasatinib |
Brain lower grade glioma |
0.001909352 |
Sensitive |
| ENSG00000230641.1 |
Dasatinib |
Brain lower grade glioma |
0.03915558 |
Sensitive |
| ENSG00000230798.1 |
Dasatinib |
Brain lower grade glioma |
0.04459685 |
Sensitive |
| ENSG00000230812.1 |
Dasatinib |
Brain lower grade glioma |
0.000358241 |
Sensitive |
| ENSG00000231518.1 |
Dasatinib |
Brain lower grade glioma |
0.046727514 |
Sensitive |
| ENSG00000232480.1 |
Dasatinib |
Brain lower grade glioma |
0.01315439 |
Sensitive |
| ENSG00000232533.1 |
Dasatinib |
Brain lower grade glioma |
0.009396728 |
Sensitive |
| ENSG00000232719.1 |
Dasatinib |
Brain lower grade glioma |
0.020850588 |
Sensitive |
| ENSG00000232725.1 |
Dasatinib |
Brain lower grade glioma |
0.002702093 |
Sensitive |
| ENSG00000232814.2 |
Dasatinib |
Brain lower grade glioma |
0.047984848 |
Sensitive |
| ENSG00000233203.2 |
Dasatinib |
Brain lower grade glioma |
0.01570889 |
Sensitive |
| ENSG00000233368.2 |
Dasatinib |
Brain lower grade glioma |
0.003988117 |
Sensitive |
| ENSG00000233429.5 |
Dasatinib |
Brain lower grade glioma |
0.005388207 |
Sensitive |
| ENSG00000233554.1 |
Dasatinib |
Brain lower grade glioma |
0.049332118 |
Sensitive |
| ENSG00000233559.1 |
Dasatinib |
Brain lower grade glioma |
0.005074451 |
Sensitive |
| ENSG00000233621.1 |
Dasatinib |
Brain lower grade glioma |
0.034689058 |
Sensitive |
| ENSG00000233817.1 |
Dasatinib |
Brain lower grade glioma |
0.026592775 |
Sensitive |
| ENSG00000233845.1 |
Dasatinib |
Brain lower grade glioma |
0.021840474 |
Sensitive |
| ENSG00000234076.1 |
Dasatinib |
Brain lower grade glioma |
0.024993211 |
Sensitive |
| ENSG00000234147.1 |
Dasatinib |
Brain lower grade glioma |
0.025169466 |
Sensitive |
| ENSG00000234264.1 |
Dasatinib |
Brain lower grade glioma |
0.017977052 |
Sensitive |
| ENSG00000234380.1 |
Dasatinib |
Brain lower grade glioma |
0.034287838 |
Sensitive |
| ENSG00000234393.1 |
Dasatinib |
Brain lower grade glioma |
0.035700323 |
Sensitive |
| ENSG00000234779.1 |
Dasatinib |
Brain lower grade glioma |
0.047055491 |
Sensitive |
| ENSG00000234883.2 |
Dasatinib |
Brain lower grade glioma |
0.045110307 |
Sensitive |
| ENSG00000235398.4 |
Dasatinib |
Brain lower grade glioma |
0.001132859 |
Sensitive |
| ENSG00000235664.1 |
Dasatinib |
Brain lower grade glioma |
0.044159465 |
Sensitive |
| ENSG00000235802.1 |
Dasatinib |
Brain lower grade glioma |
0.020748084 |
Sensitive |
| ENSG00000235884.2 |
Dasatinib |
Brain lower grade glioma |
0.048804448 |
Sensitive |
| ENSG00000235927.2 |
Dasatinib |
Brain lower grade glioma |
0.043747998 |
Sensitive |
| ENSG00000235999.1 |
Dasatinib |
Brain lower grade glioma |
0.002757273 |
Sensitive |
| ENSG00000236098.1 |
Dasatinib |
Brain lower grade glioma |
0.009249429 |
Sensitive |
| ENSG00000236581.4 |
Dasatinib |
Brain lower grade glioma |
0.048259453 |
Sensitive |
| ENSG00000236830.2 |
Dasatinib |
Brain lower grade glioma |
0.020645975 |
Sensitive |
| ENSG00000236914.3 |
Dasatinib |
Brain lower grade glioma |
0.045671528 |
Sensitive |
| ENSG00000236943.2 |
Dasatinib |
Brain lower grade glioma |
0.004500766 |
Sensitive |
| ENSG00000237424.1 |
Dasatinib |
Brain lower grade glioma |
0.001788918 |
Sensitive |
| ENSG00000237523.1 |
Dasatinib |
Brain lower grade glioma |
0.033286526 |
Sensitive |
| ENSG00000237543.1 |
Dasatinib |
Brain lower grade glioma |
0.041375872 |
Sensitive |
| ENSG00000237753.1 |
Dasatinib |
Brain lower grade glioma |
0.038047917 |
Sensitive |
| ENSG00000238005.2 |
Dasatinib |
Brain lower grade glioma |
0.047078244 |
Sensitive |
| ENSG00000238279.1 |
Dasatinib |
Brain lower grade glioma |
0.042859238 |
Sensitive |
| ENSG00000239801.1 |
Dasatinib |
Brain lower grade glioma |
0.008518086 |
Sensitive |
| ENSG00000240032.1 |
Dasatinib |
Brain lower grade glioma |
0.014978075 |
Sensitive |
| ENSG00000240350.1 |
Dasatinib |
Brain lower grade glioma |
0.037958266 |
Sensitive |
| ENSG00000240440.1 |
Dasatinib |
Brain lower grade glioma |
0.034560901 |
Sensitive |
| ENSG00000241313.2 |
Dasatinib |
Brain lower grade glioma |
0.03302805 |
Sensitive |
| ENSG00000241316.2 |
Dasatinib |
Brain lower grade glioma |
0.013956384 |
Sensitive |
| ENSG00000242396.1 |
Dasatinib |
Brain lower grade glioma |
0.020014854 |
Sensitive |
| ENSG00000243415.2 |
Dasatinib |
Brain lower grade glioma |
0.033744712 |
Sensitive |
| ENSG00000244459.2 |
Dasatinib |
Brain lower grade glioma |
0.032211023 |
Sensitive |
| ENSG00000244578.1 |
Dasatinib |
Brain lower grade glioma |
0.028032833 |
Sensitive |
| ENSG00000245571.2 |
Dasatinib |
Brain lower grade glioma |
0.00132514 |
Sensitive |
| ENSG00000246225.2 |
Dasatinib |
Brain lower grade glioma |
0.039978048 |
Sensitive |
| ENSG00000246523.3 |
Dasatinib |
Brain lower grade glioma |
0.015001441 |
Sensitive |
| ENSG00000246640.1 |
Dasatinib |
Brain lower grade glioma |
0.004678928 |
Sensitive |
| ENSG00000247311.2 |
Dasatinib |
Brain lower grade glioma |
0.006786555 |
Sensitive |
| ENSG00000248079.2 |
Dasatinib |
Brain lower grade glioma |
0.033786959 |
Sensitive |
| ENSG00000248100.2 |
Dasatinib |
Brain lower grade glioma |
0.017710947 |
Sensitive |
| ENSG00000249249.1 |
Dasatinib |
Brain lower grade glioma |
0.01106054 |
Sensitive |
| ENSG00000249740.1 |
Dasatinib |
Brain lower grade glioma |
0.041163411 |
Sensitive |
| ENSG00000250320.1 |
Dasatinib |
Brain lower grade glioma |
0.017034403 |
Sensitive |
| ENSG00000251131.1 |
Dasatinib |
Brain lower grade glioma |
0.012927634 |
Sensitive |
| ENSG00000251307.1 |
Dasatinib |
Brain lower grade glioma |
0.048451666 |
Sensitive |
| ENSG00000253227.1 |
Dasatinib |
Brain lower grade glioma |
0.020093453 |
Sensitive |
| ENSG00000253395.1 |
Dasatinib |
Brain lower grade glioma |
0.016544443 |
Sensitive |
| ENSG00000253408.1 |
Dasatinib |
Brain lower grade glioma |
0.020783734 |
Sensitive |
| ENSG00000253552.3 |
Dasatinib |
Brain lower grade glioma |
0.041803788 |
Sensitive |
| ENSG00000253616.1 |
Dasatinib |
Brain lower grade glioma |
0.01048537 |
Sensitive |
| ENSG00000253660.1 |
Dasatinib |
Brain lower grade glioma |
0.031254877 |
Sensitive |
| ENSG00000253737.1 |
Dasatinib |
Brain lower grade glioma |
0.047663024 |
Sensitive |
| ENSG00000254333.1 |
Dasatinib |
Brain lower grade glioma |
0.0000957 |
Sensitive |
| ENSG00000254363.2 |
Dasatinib |
Brain lower grade glioma |
0.020238232 |
Sensitive |
| ENSG00000254389.2 |
Dasatinib |
Brain lower grade glioma |
0.021589174 |
Sensitive |
| ENSG00000255026.1 |
Dasatinib |
Brain lower grade glioma |
0.024197278 |
Sensitive |
| ENSG00000255139.1 |
Dasatinib |
Brain lower grade glioma |
0.001154926 |
Sensitive |
| ENSG00000255198.3 |
Dasatinib |
Brain lower grade glioma |
0.014157894 |
Sensitive |
| ENSG00000255276.1 |
Dasatinib |
Brain lower grade glioma |
0.049516407 |
Sensitive |
| ENSG00000255471.1 |
Dasatinib |
Brain lower grade glioma |
0.0000503 |
Sensitive |
| ENSG00000255509.2 |
Dasatinib |
Brain lower grade glioma |
0.049445149 |
Sensitive |
| ENSG00000255557.1 |
Dasatinib |
Brain lower grade glioma |
0.010917393 |
Sensitive |
| ENSG00000257221.1 |
Dasatinib |
Brain lower grade glioma |
0.04593343 |
Sensitive |
| ENSG00000258086.1 |
Dasatinib |
Brain lower grade glioma |
0.033557615 |
Sensitive |
| ENSG00000258919.1 |
Dasatinib |
Brain lower grade glioma |
0.010017728 |
Sensitive |
| ENSG00000259062.1 |
Dasatinib |
Brain lower grade glioma |
0.033251355 |
Sensitive |
| ENSG00000259354.1 |
Dasatinib |
Brain lower grade glioma |
0.036617272 |
Sensitive |
| ENSG00000259523.1 |
Dasatinib |
Brain lower grade glioma |
0.015526735 |
Sensitive |
| ENSG00000259705.1 |
Dasatinib |
Brain lower grade glioma |
0.002056658 |
Sensitive |
| ENSG00000259883.1 |
Dasatinib |
Brain lower grade glioma |
0.046066577 |
Sensitive |
| ENSG00000260328.1 |
Dasatinib |
Brain lower grade glioma |
0.046824238 |
Sensitive |
| ENSG00000260336.1 |
Dasatinib |
Brain lower grade glioma |
0.007904547 |
Sensitive |
| ENSG00000260352.1 |
Dasatinib |
Brain lower grade glioma |
0.000376057 |
Sensitive |
| ENSG00000260578.1 |
Dasatinib |
Brain lower grade glioma |
0.043229258 |
Sensitive |
| ENSG00000260604.1 |
Dasatinib |
Brain lower grade glioma |
0.028161688 |
Sensitive |
| ENSG00000260693.1 |
Dasatinib |
Brain lower grade glioma |
0.036588772 |
Sensitive |
| ENSG00000260877.1 |
Dasatinib |
Brain lower grade glioma |
0.045118008 |
Sensitive |
| ENSG00000260910.1 |
Dasatinib |
Brain lower grade glioma |
0.019914331 |
Sensitive |
| ENSG00000261051.1 |
Dasatinib |
Brain lower grade glioma |
0.011280382 |
Sensitive |
| ENSG00000261064.1 |
Dasatinib |
Brain lower grade glioma |
0.003459746 |
Sensitive |
| ENSG00000261295.1 |
Dasatinib |
Brain lower grade glioma |
0.028628554 |
Sensitive |
| ENSG00000261341.1 |
Dasatinib |
Brain lower grade glioma |
0.043182775 |
Sensitive |
| ENSG00000261512.2 |
Dasatinib |
Brain lower grade glioma |
0.010879527 |
Sensitive |
| ENSG00000261513.1 |
Dasatinib |
Brain lower grade glioma |
0.047802362 |
Sensitive |
| ENSG00000261737.1 |
Dasatinib |
Brain lower grade glioma |
0.029889766 |
Sensitive |
| ENSG00000261801.1 |
Dasatinib |
Brain lower grade glioma |
0.042574031 |
Sensitive |
| ENSG00000261971.2 |
Dasatinib |
Brain lower grade glioma |
0.023456012 |
Sensitive |
| ENSG00000262001.1 |
Dasatinib |
Brain lower grade glioma |
0.032994181 |
Sensitive |
| ENSG00000263105.1 |
Dasatinib |
Brain lower grade glioma |
0.048474244 |
Sensitive |
| ENSG00000263680.2 |
Dasatinib |
Brain lower grade glioma |
0.034611117 |
Sensitive |
| ENSG00000266278.1 |
Dasatinib |
Brain lower grade glioma |
0.019066143 |
Sensitive |
| ENSG00000266903.1 |
Dasatinib |
Brain lower grade glioma |
0.034761676 |
Sensitive |
| ENSG00000266947.1 |
Dasatinib |
Brain lower grade glioma |
0.003805339 |
Sensitive |
| ENSG00000267475.1 |
Dasatinib |
Brain lower grade glioma |
0.000137762 |
Sensitive |
| ENSG00000267745.1 |
Dasatinib |
Brain lower grade glioma |
0.003431453 |
Sensitive |
| ENSG00000268746.1 |
Dasatinib |
Brain lower grade glioma |
0.042565753 |
Sensitive |
| ENSG00000269202.1 |
Dasatinib |
Brain lower grade glioma |
0.00369343 |
Sensitive |
| ENSG00000269966.1 |
Dasatinib |
Brain lower grade glioma |
0.048592285 |
Sensitive |
| ENSG00000269976.1 |
Dasatinib |
Brain lower grade glioma |
0.009425155 |
Sensitive |
| ENSG00000270069.1 |
Dasatinib |
Brain lower grade glioma |
0.019660105 |
Sensitive |
| ENSG00000270210.1 |
Dasatinib |
Brain lower grade glioma |
0.037953646 |
Sensitive |
| ENSG00000271590.1 |
Dasatinib |
Brain lower grade glioma |
0.014907381 |
Sensitive |
| ENSG00000271646.1 |
Dasatinib |
Brain lower grade glioma |
0.022221691 |
Sensitive |
| ENSG00000272003.1 |
Dasatinib |
Brain lower grade glioma |
0.030776996 |
Sensitive |
| ENSG00000272065.1 |
Dasatinib |
Brain lower grade glioma |
0.040511845 |
Sensitive |
| ENSG00000272366.1 |
Dasatinib |
Brain lower grade glioma |
0.042545285 |
Sensitive |
| ENSG00000272430.1 |
Dasatinib |
Brain lower grade glioma |
0.00077924 |
Sensitive |
| ENSG00000272574.1 |
Dasatinib |
Brain lower grade glioma |
0.033339134 |
Sensitive |
| ENSG00000272666.1 |
Dasatinib |
Brain lower grade glioma |
0.041260915 |
Sensitive |
| ENSG00000272691.1 |
Dasatinib |
Brain lower grade glioma |
0.008853375 |
Sensitive |
| ENSG00000272695.1 |
Dasatinib |
Brain lower grade glioma |
0.012585939 |
Sensitive |
| ENSG00000272755.1 |
Dasatinib |
Brain lower grade glioma |
0.031248158 |
Sensitive |
| ENSG00000272760.1 |
Dasatinib |
Brain lower grade glioma |
0.023356295 |
Sensitive |
| ENSG00000272782.1 |
Dasatinib |
Brain lower grade glioma |
0.002926819 |
Sensitive |
| ENSG00000272788.1 |
Dasatinib |
Brain lower grade glioma |
0.024842985 |
Sensitive |
| ENSG00000272950.1 |
Dasatinib |
Brain lower grade glioma |
0.006365115 |
Sensitive |
| ENSG00000273186.1 |
Dasatinib |
Brain lower grade glioma |
0.01559763 |
Sensitive |
| ENSG00000273311.1 |
Dasatinib |
Brain lower grade glioma |
0.006658344 |
Sensitive |
| ENSG00000273443.1 |
Dasatinib |
Brain lower grade glioma |
0.030005957 |
Sensitive |
| ENSG00000124915.6 |
Dasatinib |
Lung squamous cell carcinoma |
0.030815197 |
Sensitive |
| ENSG00000146666.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.011345548 |
Sensitive |
| ENSG00000170919.11 |
Dasatinib |
Lung squamous cell carcinoma |
0.012634043 |
Sensitive |
| ENSG00000172965.10 |
Dasatinib |
Lung squamous cell carcinoma |
0.0000574 |
Sensitive |
| ENSG00000175061.13 |
Dasatinib |
Lung squamous cell carcinoma |
0.011696019 |
Sensitive |
| ENSG00000177410.8 |
Dasatinib |
Lung squamous cell carcinoma |
0.006503447 |
Sensitive |
| ENSG00000182021.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.023976194 |
Sensitive |
| ENSG00000186594.8 |
Dasatinib |
Lung squamous cell carcinoma |
0.001156092 |
Sensitive |
| ENSG00000189149.7 |
Dasatinib |
Lung squamous cell carcinoma |
0.045672903 |
Sensitive |
| ENSG00000189419.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.048744821 |
Sensitive |
| ENSG00000197670.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.009070959 |
Sensitive |
| ENSG00000203999.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.014438261 |
Sensitive |
| ENSG00000204054.7 |
Dasatinib |
Lung squamous cell carcinoma |
0.031542146 |
Sensitive |
| ENSG00000204362.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.033968885 |
Sensitive |
| ENSG00000206573.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.040277591 |
Sensitive |
| ENSG00000221817.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.000720039 |
Sensitive |
| ENSG00000222041.6 |
Dasatinib |
Lung squamous cell carcinoma |
0.014865715 |
Sensitive |
| ENSG00000223477.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.020386107 |
Sensitive |
| ENSG00000223725.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.048218039 |
Sensitive |
| ENSG00000223797.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.020848985 |
Sensitive |
| ENSG00000224063.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.047771252 |
Sensitive |
| ENSG00000224687.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.026417023 |
Sensitive |
| ENSG00000224818.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.018834723 |
Sensitive |
| ENSG00000224848.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030718353 |
Sensitive |
| ENSG00000224897.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.036006299 |
Sensitive |
| ENSG00000224959.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.008503227 |
Sensitive |
| ENSG00000225039.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022837442 |
Sensitive |
| ENSG00000225541.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.031794258 |
Sensitive |
| ENSG00000225684.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.021592622 |
Sensitive |
| ENSG00000225914.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030062075 |
Sensitive |
| ENSG00000226312.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.035511536 |
Sensitive |
| ENSG00000226334.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.032996542 |
Sensitive |
| ENSG00000226380.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.001880696 |
Sensitive |
| ENSG00000226445.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.047111107 |
Sensitive |
| ENSG00000227200.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.040202585 |
Sensitive |
| ENSG00000227959.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033663387 |
Sensitive |
| ENSG00000228022.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033182097 |
Sensitive |
| ENSG00000228288.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.042810247 |
Sensitive |
| ENSG00000228649.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.006324203 |
Sensitive |
| ENSG00000229118.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.003215947 |
Sensitive |
| ENSG00000229618.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.013698258 |
Sensitive |
| ENSG00000229656.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.030397708 |
Sensitive |
| ENSG00000229951.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.006128982 |
Sensitive |
| ENSG00000230082.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.018333995 |
Sensitive |
| ENSG00000230479.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.006477054 |
Sensitive |
| ENSG00000231242.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.037811863 |
Sensitive |
| ENSG00000231290.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.010622486 |
Sensitive |
| ENSG00000231312.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.012633416 |
Sensitive |
| ENSG00000231528.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.020675445 |
Sensitive |
| ENSG00000231742.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.025190762 |
Sensitive |
| ENSG00000231948.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.017828646 |
Sensitive |
| ENSG00000232082.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.007767075 |
Sensitive |
| ENSG00000232533.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.016238063 |
Sensitive |
| ENSG00000232656.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.038930429 |
Sensitive |
| ENSG00000232677.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.036033618 |
Sensitive |
| ENSG00000232759.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.026816467 |
Sensitive |
| ENSG00000232907.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.040068068 |
Sensitive |
| ENSG00000233077.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.007471407 |
Sensitive |
| ENSG00000233237.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.029246279 |
Sensitive |
| ENSG00000233547.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.048319199 |
Sensitive |
| ENSG00000233766.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.032807016 |
Sensitive |
| ENSG00000233818.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001508106 |
Sensitive |
| ENSG00000234292.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.026879002 |
Sensitive |
| ENSG00000234380.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.028550736 |
Sensitive |
| ENSG00000234616.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.02674536 |
Sensitive |
| ENSG00000234817.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.049963078 |
Sensitive |
| ENSG00000235204.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.043414175 |
Sensitive |
| ENSG00000235781.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.012000945 |
Sensitive |
| ENSG00000235927.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.045747784 |
Sensitive |
| ENSG00000236064.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.01236115 |
Sensitive |
| ENSG00000236098.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.036798582 |
Sensitive |
| ENSG00000236256.5 |
Dasatinib |
Lung squamous cell carcinoma |
0.018146154 |
Sensitive |
| ENSG00000236318.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02474081 |
Sensitive |
| ENSG00000236345.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022909642 |
Sensitive |
| ENSG00000236451.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.042408278 |
Sensitive |
| ENSG00000236591.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021418249 |
Sensitive |
| ENSG00000236671.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.041707489 |
Sensitive |
| ENSG00000236751.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.003938957 |
Sensitive |
| ENSG00000236861.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.019804485 |
Sensitive |
| ENSG00000237523.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.006811831 |
Sensitive |
| ENSG00000237548.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.013462153 |
Sensitive |
| ENSG00000237813.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.003093426 |
Sensitive |
| ENSG00000237819.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.032997949 |
Sensitive |
| ENSG00000237862.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.032480857 |
Sensitive |
| ENSG00000237886.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02820984 |
Sensitive |
| ENSG00000238018.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.01499406 |
Sensitive |
| ENSG00000239353.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.009575075 |
Sensitive |
| ENSG00000239705.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.009779278 |
Sensitive |
| ENSG00000240476.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.043791703 |
Sensitive |
| ENSG00000241933.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.03322624 |
Sensitive |
| ENSG00000242125.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.014962573 |
Sensitive |
| ENSG00000242282.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.048138302 |
Sensitive |
| ENSG00000242516.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.029898408 |
Sensitive |
| ENSG00000242759.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.028578174 |
Sensitive |
| ENSG00000243243.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.009065568 |
Sensitive |
| ENSG00000243701.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044983715 |
Sensitive |
| ENSG00000243902.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.019497981 |
Sensitive |
| ENSG00000243926.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.023016378 |
Sensitive |
| ENSG00000244161.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.049226658 |
Sensitive |
| ENSG00000244479.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.003591433 |
Sensitive |
| ENSG00000245522.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.019075341 |
Sensitive |
| ENSG00000245937.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.034702179 |
Sensitive |
| ENSG00000246898.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022927523 |
Sensitive |
| ENSG00000247134.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.014430895 |
Sensitive |
| ENSG00000247311.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.017614769 |
Sensitive |
| ENSG00000248027.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.020226449 |
Sensitive |
| ENSG00000248223.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001306079 |
Sensitive |
| ENSG00000248693.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.027366001 |
Sensitive |
| ENSG00000249685.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.012380454 |
Sensitive |
| ENSG00000249740.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001277245 |
Sensitive |
| ENSG00000250303.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.027493623 |
Sensitive |
| ENSG00000250508.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.034081557 |
Sensitive |
| ENSG00000250659.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.01369849 |
Sensitive |
| ENSG00000250842.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.04834949 |
Sensitive |
| ENSG00000251003.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.013092825 |
Sensitive |
| ENSG00000251009.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.034175503 |
Sensitive |
| ENSG00000251136.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.025859725 |
Sensitive |
| ENSG00000251194.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.011365361 |
Sensitive |
| ENSG00000251359.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.032818294 |
Sensitive |
| ENSG00000251442.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.043804552 |
Sensitive |
| ENSG00000253374.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.002101833 |
Sensitive |
| ENSG00000253859.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.000975753 |
Sensitive |
| ENSG00000254057.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.045758688 |
Sensitive |
| ENSG00000254154.4 |
Dasatinib |
Lung squamous cell carcinoma |
0.011947203 |
Sensitive |
| ENSG00000254485.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.047396639 |
Sensitive |
| ENSG00000254639.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030232368 |
Sensitive |
| ENSG00000255090.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.008466007 |
Sensitive |
| ENSG00000255197.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033358899 |
Sensitive |
| ENSG00000256802.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.009448532 |
Sensitive |
| ENSG00000257261.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.027322133 |
Sensitive |
| ENSG00000257496.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.045654379 |
Sensitive |
| ENSG00000257556.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033120931 |
Sensitive |
| ENSG00000257671.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.005854414 |
Sensitive |
| ENSG00000258122.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021224267 |
Sensitive |
| ENSG00000258457.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022728968 |
Sensitive |
| ENSG00000258534.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.040345797 |
Sensitive |
| ENSG00000258929.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.034142564 |
Sensitive |
| ENSG00000258955.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.02113537 |
Sensitive |
| ENSG00000258976.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.047229506 |
Sensitive |
| ENSG00000259001.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.039227261 |
Sensitive |
| ENSG00000259065.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033814414 |
Sensitive |
| ENSG00000259146.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.035074865 |
Sensitive |
| ENSG00000259198.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.032531749 |
Sensitive |
| ENSG00000259417.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.03433447 |
Sensitive |
| ENSG00000259426.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.010680487 |
Sensitive |
| ENSG00000259523.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001478863 |
Sensitive |
| ENSG00000259656.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.010768686 |
Sensitive |
| ENSG00000259727.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021640055 |
Sensitive |
| ENSG00000260046.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.049539768 |
Sensitive |
| ENSG00000260156.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.034777425 |
Sensitive |
| ENSG00000260896.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.023146611 |
Sensitive |
| ENSG00000260938.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.045022311 |
Sensitive |
| ENSG00000261220.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.01681376 |
Sensitive |
| ENSG00000261295.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.004847708 |
Sensitive |
| ENSG00000261468.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.037413452 |
Sensitive |
| ENSG00000261512.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.034459174 |
Sensitive |
| ENSG00000261592.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022137178 |
Sensitive |
| ENSG00000261655.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.049350013 |
Sensitive |
| ENSG00000261662.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.045298209 |
Sensitive |
| ENSG00000262136.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021254441 |
Sensitive |
| ENSG00000262686.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.031459686 |
Sensitive |
| ENSG00000263466.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.000139771 |
Sensitive |
| ENSG00000263874.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.029407594 |
Sensitive |
| ENSG00000263934.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.04738554 |
Sensitive |
| ENSG00000264107.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.008210432 |
Sensitive |
| ENSG00000264673.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.027327925 |
Sensitive |
| ENSG00000264729.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.028197872 |
Sensitive |
| ENSG00000264932.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.04874087 |
Sensitive |
| ENSG00000265888.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001185451 |
Sensitive |
| ENSG00000266340.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.036563775 |
Sensitive |
| ENSG00000266401.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042270466 |
Sensitive |
| ENSG00000266538.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.009622126 |
Sensitive |
| ENSG00000266651.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.014996398 |
Sensitive |
| ENSG00000267082.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.031364327 |
Sensitive |
| ENSG00000267141.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042117275 |
Sensitive |
| ENSG00000267213.3 |
Dasatinib |
Lung squamous cell carcinoma |
0.035365722 |
Sensitive |
| ENSG00000267288.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.036800339 |
Sensitive |
| ENSG00000267745.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.036210444 |
Sensitive |
| ENSG00000268157.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.014948402 |
Sensitive |
| ENSG00000268520.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.04143423 |
Sensitive |
| ENSG00000268584.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042569668 |
Sensitive |
| ENSG00000268812.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.024335742 |
Sensitive |
| ENSG00000268889.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.035542334 |
Sensitive |
| ENSG00000269481.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.020908564 |
Sensitive |
| ENSG00000269640.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.027093405 |
Sensitive |
| ENSG00000269680.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.014035594 |
Sensitive |
| ENSG00000269893.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.015826625 |
Sensitive |
| ENSG00000269895.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.020057899 |
Sensitive |
| ENSG00000269900.2 |
Dasatinib |
Lung squamous cell carcinoma |
0.018035703 |
Sensitive |
| ENSG00000269927.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.044117634 |
Sensitive |
| ENSG00000269966.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.036891083 |
Sensitive |
| ENSG00000270000.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.03764958 |
Sensitive |
| ENSG00000270069.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.009584132 |
Sensitive |
| ENSG00000270190.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.049715052 |
Sensitive |
| ENSG00000271020.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.015822321 |
Sensitive |
| ENSG00000271324.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.03658403 |
Sensitive |
| ENSG00000271590.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.030508656 |
Sensitive |
| ENSG00000271631.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.042868837 |
Sensitive |
| ENSG00000271643.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001034991 |
Sensitive |
| ENSG00000271762.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.033587208 |
Sensitive |
| ENSG00000271826.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.001239192 |
Sensitive |
| ENSG00000271862.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.011307341 |
Sensitive |
| ENSG00000272103.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.007409431 |
Sensitive |
| ENSG00000272121.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.045675321 |
Sensitive |
| ENSG00000272142.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.040853633 |
Sensitive |
| ENSG00000272146.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.017339462 |
Sensitive |
| ENSG00000272265.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.024683523 |
Sensitive |
| ENSG00000272473.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.022981573 |
Sensitive |
| ENSG00000272620.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.036794948 |
Sensitive |
| ENSG00000272709.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.012996798 |
Sensitive |
| ENSG00000272791.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.047139977 |
Sensitive |
| ENSG00000273038.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.034268248 |
Sensitive |
| ENSG00000273065.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.021687745 |
Sensitive |
| ENSG00000273102.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.004502653 |
Sensitive |
| ENSG00000273443.1 |
Dasatinib |
Lung squamous cell carcinoma |
0.023321233 |
Sensitive |
| ENSG00000175773.8 |
Dasatinib |
Skin cutaneous melanoma |
0.046199022 |
Sensitive |
| ENSG00000186019.10 |
Dasatinib |
Skin cutaneous melanoma |
0.037084393 |
Sensitive |
| ENSG00000204272.6 |
Dasatinib |
Skin cutaneous melanoma |
0.046798659 |
Sensitive |
| ENSG00000223380.3 |
Dasatinib |
Skin cutaneous melanoma |
0.018306206 |
Sensitive |
| ENSG00000224846.1 |
Dasatinib |
Skin cutaneous melanoma |
0.011244694 |
Sensitive |
| ENSG00000226328.2 |
Dasatinib |
Skin cutaneous melanoma |
0.029513291 |
Sensitive |
| ENSG00000226869.2 |
Dasatinib |
Skin cutaneous melanoma |
0.006243466 |
Sensitive |
| ENSG00000226889.3 |
Dasatinib |
Skin cutaneous melanoma |
0.029675645 |
Sensitive |
| ENSG00000227527.2 |
Dasatinib |
Skin cutaneous melanoma |
0.007045747 |
Sensitive |
| ENSG00000228614.1 |
Dasatinib |
Skin cutaneous melanoma |
0.045513203 |
Sensitive |
| ENSG00000229750.1 |
Dasatinib |
Skin cutaneous melanoma |
0.012646175 |
Sensitive |
| ENSG00000230470.1 |
Dasatinib |
Skin cutaneous melanoma |
0.018929802 |
Sensitive |
| ENSG00000234832.1 |
Dasatinib |
Skin cutaneous melanoma |
0.03492912 |
Sensitive |
| ENSG00000235586.1 |
Dasatinib |
Skin cutaneous melanoma |
0.03630305 |
Sensitive |
| ENSG00000236824.1 |
Dasatinib |
Skin cutaneous melanoma |
0.044855594 |
Sensitive |
| ENSG00000242154.1 |
Dasatinib |
Skin cutaneous melanoma |
0.039413601 |
Sensitive |
| ENSG00000244649.2 |
Dasatinib |
Skin cutaneous melanoma |
0.006460321 |
Sensitive |
| ENSG00000248724.2 |
Dasatinib |
Skin cutaneous melanoma |
0.040381416 |
Sensitive |
| ENSG00000249375.3 |
Dasatinib |
Skin cutaneous melanoma |
0.012179156 |
Sensitive |
| ENSG00000253121.1 |
Dasatinib |
Skin cutaneous melanoma |
0.015353688 |
Sensitive |
| ENSG00000253490.1 |
Dasatinib |
Skin cutaneous melanoma |
0.016511344 |
Sensitive |
| ENSG00000254099.1 |
Dasatinib |
Skin cutaneous melanoma |
0.04184929 |
Sensitive |
| ENSG00000255723.1 |
Dasatinib |
Skin cutaneous melanoma |
0.045090454 |
Sensitive |
| ENSG00000258642.1 |
Dasatinib |
Skin cutaneous melanoma |
0.021176635 |
Sensitive |
| ENSG00000258920.1 |
Dasatinib |
Skin cutaneous melanoma |
0.049797665 |
Sensitive |
| ENSG00000258940.2 |
Dasatinib |
Skin cutaneous melanoma |
0.012298244 |
Sensitive |
| ENSG00000258957.1 |
Dasatinib |
Skin cutaneous melanoma |
0.004433641 |
Sensitive |
| ENSG00000259118.1 |
Dasatinib |
Skin cutaneous melanoma |
0.01501127 |
Sensitive |
| ENSG00000260209.1 |
Dasatinib |
Skin cutaneous melanoma |
0.035534449 |
Sensitive |
| ENSG00000260858.1 |
Dasatinib |
Skin cutaneous melanoma |
0.037520643 |
Sensitive |
| ENSG00000261329.1 |
Dasatinib |
Skin cutaneous melanoma |
0.033808934 |
Sensitive |
| ENSG00000266445.1 |
Dasatinib |
Skin cutaneous melanoma |
0.032618309 |
Sensitive |
| ENSG00000269481.1 |
Dasatinib |
Skin cutaneous melanoma |
0.019477407 |
Sensitive |
| ENSG00000269640.1 |
Dasatinib |
Skin cutaneous melanoma |
0.033810411 |
Sensitive |
| ENSG00000270022.2 |
Dasatinib |
Skin cutaneous melanoma |
0.047894814 |
Sensitive |
| ENSG00000271430.1 |
Dasatinib |
Skin cutaneous melanoma |
0.024712229 |
Sensitive |
| ENSG00000272123.1 |
Dasatinib |
Skin cutaneous melanoma |
0.045426292 |
Sensitive |
